EP0226592A1 - Liquid crystal phase. - Google Patents

Liquid crystal phase.

Info

Publication number
EP0226592A1
EP0226592A1 EP86901864A EP86901864A EP0226592A1 EP 0226592 A1 EP0226592 A1 EP 0226592A1 EP 86901864 A EP86901864 A EP 86901864A EP 86901864 A EP86901864 A EP 86901864A EP 0226592 A1 EP0226592 A1 EP 0226592A1
Authority
EP
European Patent Office
Prior art keywords
trans
phe
pentylcyclohexyl
dioxane
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP86901864A
Other languages
German (de)
French (fr)
Other versions
EP0226592B1 (en
Inventor
Bernhard Scheuble
Georg Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of EP0226592A1 publication Critical patent/EP0226592A1/en
Application granted granted Critical
Publication of EP0226592B1 publication Critical patent/EP0226592B1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40

Definitions

  • the invention relates to liquid-crystalline phases (LC phases) with low viscosity, broad nematic phases and low temperature dependence of the threshold voltage.
  • LC display elements For liquid crystal display elements (LC display elements), the properties of nematic or nematic-cholesteric liquid-crystalline materials are increasingly being used to significantly change their optical properties such as light absorption, light scattering, birefringence, reflectivity or color under the influence of electrical fields.
  • the function of such display elements is based, for example, on the phenomena of dynamic scattering, the deformation of aligned phases, the guest-host effect, the Schadt-Helfrich effect in the twisted cell, the SBE effect or the cholesteric-nematic phase transition.
  • liquid-crystalline phases are required, which have to meet a variety of requirements. Chemical resistance to moisture, air and physical influences such as heat, radiation in the infrared, visible and ultraviolet range and electrical equal and alternating fields are particularly important here. Furthermore, from technical usable liquid-crystalline dielectrics required a liquid-crystalline mesophase in a suitable temperature range and the lowest possible viscosity at room temperature. After all, they must have no self-absorption in the visible light range, ie they must be colorless.
  • the invention is based on the object of producing liquid-crystalline phases which have a nematic phase in the required temperature range, enable sufficiently short switching times in liquid-crystal cells at room temperature, have low temperature dependency of the threshold voltage and have extremely high chemical stability.
  • a large number of liquid-crystalline phases based on a large number of compounds are already commercially available. However, there is still a great need for liquid crystalline phases with high clearing points, low melting points, low viscosity (and thus short switching times), low temperature dependence of the threshold voltage and high chemical stability, which are suitable for multiplex operation.
  • the LC phases currently commercially available generally contain considerable amounts of ester compounds, for example of the formula
  • R is n-alkyl or n-oxaalkyl and R 'n-alkyl, n-alkoxy, n-oxaalkyl or CN.
  • R 1 is alkyl having 1 to 12 C atoms
  • R 2 alkyl, alkoxy or alkanoyloxy each having 1 to 12 C atoms
  • Ph 1,4-phenylene, at least one component of formula II
  • R 3 and R 4 are each alkyl having 1 to 12 carbon atoms
  • Phe in each case means 1,4-phenylene which is unsubstituted or substituted by a fluorine
  • R 5 in each case alkyl with 1 to 12 C atoms, R 6 alkyl, alkoxy or alkanoyloxy with in each case 1 to 12 C atoms, m 0 or 1,
  • Pyr pyrimidine-2,5-diyl or pyridine-2,5-diyl and A 1 means Phe or Cy and Cy and Phe have the meanings given, and / or at least one component selected from the compounds of the formulas IVa and IVb
  • the phases according to the invention preferably additionally comprise at least one component selected from the compounds of the formulas Va and Vb,
  • R 8 each represents alkyl having 1 to 12 carbon atoms, n represents 1 or 2 and Cy and Phe each have the meanings given.
  • R 9 is alkyl having 1 to 12 carbon atoms, R 10 alkyl or alkoxy each having 1 to
  • Z means -CO-O-, -O-CO- or -CH 2 CH 2 -.
  • the invention thus relates to the liquid crystal phases described above, which may also contain two or more pleochroic dyes, and the use of these phases in liquid crystal display elements.
  • the invention furthermore relates to liquid crystal display elements which contain such phases.
  • pleochroic dyes suitable for guest-host mixtures can be used as dyes.
  • the most important of these dyes belong to the classes of antrachinone, naphthoquinone, azo, indigo and / or perylene dyes.
  • the guest-host systems according to the invention can be adapted to a wide variety of applications.
  • alkoxy or alkanoyloxy means -O-alkyl or -O-CO-alkyl.
  • Alkyl preferably means methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-alkoxymethyl or n-alkoxyethyl, preferably in each case 2 to 7 carbon atoms or trans-alkenyl with 3 to 7 carbon atoms.
  • alkyl groups of the components of the formulas I to VI contain 3 or more carbon atoms, these can be arranged in a straight or branched chain. However, no components are used in the phases according to the invention which contain more than one branched alkyl group. Such branched alkyl groups do not contain in the context of the present invention more than one chain branch; it is preferably a methyl or ethylene group in the 1- or 2-position of the carbon skeleton, so that the following are particularly suitable as branched alkyl groups: 2-methylpropyl, 2-methylbutyl, 1-methylpentyl, 2-methylpentyl, 1-methylhexyl .
  • the liquid-crystalline dielectrics according to the invention contain only one component with a branched-chain alkyl radical in order to induce optical activity if desired.
  • a component with a branched alkyl radical normally no more than 10% by weight, preferably 0.5 to 3% by weight, of a component with a branched alkyl radical is added.
  • compounds of the formula I to IV in which the alkyl radicals are straight-chain, ie methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl are preferably used as components of the phase according to the invention.
  • A is preferably Cy.
  • Z 1 and Z 2 in formula II preferably each represent a single bond. Preference is furthermore given to compounds of the formula II in which one of the groups Z 1 and Z 2 denotes -CH 2 CH 2 - and the other
  • Q is preferably Phe.
  • the LC phases according to the invention preferably contain
  • LC phases according to the invention containing 10 to 22% of one or more components of the formula I.
  • R is preferably n-alkyl or n- (trans ) Alkenyl with 2 to 7, in particular with 3 to 5, carbon atoms or an oxaalkyl group with 2 to 6 carbon atoms.
  • R 2 is preferably n-alkyl or n-alkoxy, each having 1 to 5 carbon atoms.
  • the LC phases according to the invention contain at least one compound of the formula I in which R 2 is n-alkoxy.
  • the LC phases according to the invention preferably contain 5 to 45, in particular 5-35% of one or more components of the formula II. Particular preference is given to
  • LC phases containing 12 to 27% of one or more components of the formula II.
  • R 3 and R 4 are each preferably independently of one another n-alkyl or n-oxaalkyl each having 2 to 7, in particular 3 to 5, carbon atoms.
  • the LC phases preferably contain at least one compound of the formula I in which A ° is trans-1,4-cyclohexylene and / or one group Phe is 2-fluoro-1,4-phenylene and the other group is Phe 1,4-phenylene .
  • Formula II preferably comprises compounds of the partial form in IIa to m:
  • the LC phases according to the invention preferably contain both at least one compound of the formula II in which A ° denotes a single bond and at least one compound of the formula II in which A ° denotes trans-1,4-cyclohexylene.
  • the LC phases according to the invention preferably contain
  • LC phases containing 21 to 33% of one or more components of the formula III.
  • m is preferably 0.
  • R 5 is preferably n-alkyl having 3 to 12, in particular 6 to 9, carbon atoms.
  • R 6 is preferably n-alkoxy or n-alkyl having 1 to 12 carbon atoms.
  • FK phases preferably contain at least three, in particular at least five, compounds of the formula III.
  • Formula III a preferably comprises compounds of the sub-formulas Illaa and Illab,
  • Formula Illb includes preferred compounds of the subforms in Illba, Illbb and Illbc,
  • R 5 and R 6 each preferably represent alkyl having 2 to 9 carbon atoms.
  • the LC phases according to the invention preferably contain 5 to 45, in particular 14 to 38%, of one or more components of the formula IV. Particularly preferred
  • R 7 is preferably n-alkyl having 2 to 7, in particular 2 to 5, carbon atoms.
  • Formula IVb includes compounds of the sub-formulas IVba to IVbf
  • R 7 -Cy-Ph-COO-Phe-NCS IVbf of which compounds of the formulas IVba, IVbc, IVbd and IVbe are particularly preferred.
  • R 7 is preferably straight-chain alkyl, alkoxy or (trans) alkenyl with preferably 2 to 7 carbon atoms.
  • Phe is preferably 1,4-phenylene.
  • Phases according to the invention which simultaneously contain compounds of the formulas I, II, III (a and / or b) and IV (a and / or b) are preferred. These phases preferably contain compounds of the formula IVa. Preference is furthermore given to phases which simultaneously contain compounds of the formulas I, II and IVb, these phases preferably containing trinuclear and tetranuclear compounds of the formula II (ie A ° is a single bond in one or more compounds of the formula II and one or more Compounds of the formula II Cy or Dio, preferably Cy.
  • the proportions by weight of the components of the formulas I to IV in the LC phases according to the invention are preferably in the ranges given below.
  • LC phases according to the invention containing at least one component of the formula Va and / or Vb, in which R 8 preferably denotes n-alkyl having 2 to 7 C atoms and Phe 1,4-phenylene or 3-fluoro-1,4- Is phenylene.
  • the proportion of this compound (s) is preferably in the range from 4 to 15%.
  • Compounds of formula Va are preferred.
  • LC phases according to the invention containing at least one component of the formula VI, in which R 9 is preferably n-alkyl or n-oxaalkyl having 2 to
  • R 10 is preferably n-alkyl, n-alkoxy or n-oxaalkyl each having 2 to 7 carbon atoms or CN.
  • a 1 is preferably trans-1,4-cyclohexylene or 1,4-phenylene.
  • a 2 is preferably trans-1,4-cyclohexylene or 3-fluoro-1,4-phenylene.
  • Z is preferably -CO-O- or -CH 2 CH 2 -. The proportion of these compounds is preferably 3 to 15%.
  • the phases according to the invention are produced in a conventional manner. As a rule, the desired amount of the components used in smaller amounts is dissolved in the components which make up the main constituent, advantageously at elevated temperature. If a temperature above the clearing point of the main constituent is chosen, the completeness of the dissolving process can be observed particularly easily.
  • Example mix acetone, chloroform or methanol and remove the solvent after thorough mixing, for example by distillation under reduced pressure.
  • care must be taken to ensure that no impurities or undesirable dopants are introduced by the solvent.
  • liquid-crystalline phases according to the invention can be modified so that they can be used in all types of liquid-crystal display elements which have hitherto become known.
  • conductive salts preferably ethyl-dimethyl-dodecylammonium-4-hexylocybenzoate, tetrabutylammonium-tetraphenylboranate or complex salts of crown ethers (see, for example, I. Haller et al., Mol. Cryst. Lig. Cryst. Volume 24, pages 249-258, ( 1973)) to improve the conductivity or substances to change the dielectric anisotropy, pie, the viscosity and / or the orientation of the nematic phases are added.
  • Such substances are described, for example, in DE-OS 22 09 127, 22 40 864, 23 21 632, 23 38 281, 24 50 088, 26 37 430, 28 53 728 and 29 02 177.
  • Example 6 has a melting point of -12 °, a clearing point of 65 °, a dielectric anisotropy of +7.0, an optical anisotropy of 0.1249, a threshold voltage V 10.0.20 of 2.0 volts and in the K 3 / K 1 in 0.77.
  • Example 6 has a melting point of -12 °, a clearing point of 65 °, a dielectric anisotropy of +7.0, an optical anisotropy of 0.1249, a threshold voltage V 10.0.20 of 2.0 volts and in the K 3 / K 1 in 0.77.
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • trans-1-p-methoxyphenyl-4-propylcyclohexane and 14% trans-1-p-propylphenyl-4-pentylcyclohexane has a melting point of -17 °, a clearing point of 78 °, a dielectric anisotropy of +7.0, an optical anisotropy of 0.1222, a threshold voltage V 10.0.20 of 2.1 volts and a K 3 / K 1 of 0.84.
  • a liquid-crystalline phase is produced, consisting of
  • a liquid-crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • a liquid-crystalline phase is produced consisting of
  • a liquid-crystalline phase is produced consisting of
  • a liquid-crystalline phase is produced consisting of
  • a liquid-crystalline phase is produced consisting of
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • a liquid-crystalline phase is produced consisting of
  • a liquid-crystalline phase is produced consisting of

Abstract

Une phase cristalline liquide contient au moins un composant ayant la formule I: R1-A-Ph-R2, au moins un composant ayant la formule II: R3-Cy-Z1-Q-Z2-Phe-Ao-R4, au moins un composant choisi parmi les composés ayant les formules IIIa: R5-(Cy)m-Pyr-Phe-R6 et IIIb: R5-(Cy)m-A1-Pyr-R6 et/ou au moins un composant choisi parmi les composés ayant les formules IVa: R7-Dio-Phe-CN et IVb: R7-Ao-Phe-NCS. Cette phase cristalline liquide présente de bonnes qualités de multiplexage.A liquid crystalline phase contains at least one component having the formula I: R1-A-Ph-R2, at least one component having the formula II: R3-Cy-Z1-Q-Z2-Phe-Ao-R4, at least one component chosen from the compounds having the formulas IIIa: R5- (Cy) m-Pyr-Phe-R6 and IIIb: R5- (Cy) m-A1-Pyr-R6 and / or at least one component chosen from the compounds having the formulas IVa: R7-Dio-Phe-CN and IVb: R7-Ao-Phe-NCS. This liquid crystalline phase has good multiplexing qualities.

Description

Flüssigkristall-Phase Liquid crystal phase
Die Erfindung betrifft flüssigkristalline Phasen (FK-Phasen) mit niedriger Viskosität, breiten nematischen Phasen und geringer Temperaturabhängigkeit der Schwellenspannung.The invention relates to liquid-crystalline phases (LC phases) with low viscosity, broad nematic phases and low temperature dependence of the threshold voltage.
Sie betrifft insbesondere FK-Phasen zur Verwendung in FK-Anzeigeelementen des verdrillt nematischen Typs, die für den Multiplexbetrieb geeignet sind bzw. in SBE-Anzeigen.It relates in particular to LC phases for use in LC display elements of the twisted nematic type which are suitable for multiplex operation or in SBE displays.
Für Flüssigkristall-Anzeigeelemente (FK-Anzeigeelemente) werden in zunehmendem Maße die Eigenschaften nematischer oder nematisch-cholesterischer flüssigkristalliner Materialien ausgenutzt, ihre optischen Eigenschaften wie Lichtabsorption, Lichtstreuung, Doppelbrechung, Reflexionsvermögen oder Farbe unter dem Einfluß elektrischer Felder signifikant zu verändern. Die Funktion derartiger Anzeigeelernente beruht dabei beispielsweise auf den Phänomenen der dynamischen Streuung, der Deformation aufgerichteter Phasen, dem Guest-Host-Effekt, dem Schadt-Helfrich-Effekt in der verdrillten Zelle, dem SBE-Effekt oder dem cholesterisch-nematischen Phasenübergang.For liquid crystal display elements (LC display elements), the properties of nematic or nematic-cholesteric liquid-crystalline materials are increasingly being used to significantly change their optical properties such as light absorption, light scattering, birefringence, reflectivity or color under the influence of electrical fields. The function of such display elements is based, for example, on the phenomena of dynamic scattering, the deformation of aligned phases, the guest-host effect, the Schadt-Helfrich effect in the twisted cell, the SBE effect or the cholesteric-nematic phase transition.
Für die technische Anwendung dieser Effekte in elektrooptischen Bauelementen werden flüssigkristalline Phasen benötigt, die einer Vielzahl von Anforderungen genügen müssen. Besonders wichtig sind hier die chemische Beständigkeit gegenüber Feuchtigkeit, Luft und pysikalischen Einflüssen wie Wärme, Strahlung im infraroten, sichtbaren und ultravioletten Bereich und elektrische Gleich- und Wechselfeider. Ferner wird von technisch verwendbaren flüssigkristallinen Dielektrika eine flüssigkristalline Mesophase in einem geeigneten Temperaturbereich und eine möglichst niedrige Viskosität bei Raumtemperatur gefordert. Schließlich dürfen sie im Bereich des sichtbaren Lichtes keine Eigenabsorption aufweisen, d.h., sie müssen farblos sein.For the technical application of these effects in electro-optical components, liquid-crystalline phases are required, which have to meet a variety of requirements. Chemical resistance to moisture, air and physical influences such as heat, radiation in the infrared, visible and ultraviolet range and electrical equal and alternating fields are particularly important here. Furthermore, from technical usable liquid-crystalline dielectrics required a liquid-crystalline mesophase in a suitable temperature range and the lowest possible viscosity at room temperature. After all, they must have no self-absorption in the visible light range, ie they must be colorless.
In keiner der bisher bekannten Reihen von Verbindungen mit flüssigkristalliner Mesophase gibt es eine Einzelverbindung, die allen diesen Erfordernissen entspricht. Es werden daher in der Regel Mischungen von zwei bis zwanzig, vorzugsweise drei bis fünfzehn, Verbindungen hergestellt, um als flüssigkristalline Phasen verwendbare Substanzen zu erhalten. Hierzu mischt man gewöhnlich mindestens eine Verbindung mit niedrigem Schmelz- und Klärpunkt. Hierbei wird normalerweise ein Gemisch erhalten, dessen Schmelzpunkt unter dem der niedriger schmelzenden Komponente liegt, während der Klärpunkt zwischen den Klärpunkten der Komponenten liegt. Optimale Phasen lassen sich jedoch auf diese Weise nicht leicht herstellen, da die Komponenten mit den hohenIn none of the previously known series of compounds with liquid crystalline mesophase there is a single compound which meets all of these requirements. Mixtures of two to twenty, preferably three to fifteen, compounds are therefore generally prepared in order to obtain substances which can be used as liquid-crystalline phases. This usually involves mixing at least one compound with a low melting and clearing point. This usually gives a mixture whose melting point is below that of the lower melting component, while the clearing point lies between the clearing points of the components. However, it is not easy to establish optimal phases in this way because the components with the high
Schmelz- und Klärpunkten den Gemischen häufig auch eine hohe Viskosität verleihen. Dadurch werden die Schaltzeiten der damit hergestellten elektrooptischen Anzeigeelemente in unerwünschter Weise verlängert.Melting and clearing points often also give the mixtures a high viscosity. As a result, the switching times of the electro-optical display elements produced in this way are undesirably extended.
Der Erfindung liegt die Aufgabe zugrunde, flüssigkristalline Phasen herzustellen, die eine nematiscne Phase im geforderten Temperaturbereich aufweisen, in Flüssigkristallzellen bei Raumtemperatur ausreichend kurze Schaltzeiten ermöglichen, geringe Temperaturabhängigkeit der Schwellenspannung aufweisen und eine außerordentlich hohe chemische Stabilität aufweisen. Es ist bereits eine große Anzahl flüssigkristalliner Phasen auf der Basis einer Vielzahl von Verbindungen im Handel. Es besteht jedoch immer noch ein großer Bedarf nach flüssigkristallinen Phasen mit hohen Klärpunkten, niederen Schmelzpunkten, niedriger Viskosität (und damit kurzen Schaltzeiten), geringer Temperaturabhängigkeit der Schwellenspannung und hoher chemischer Stabilität, die sich für den Mulitplexbetrieb eignen. Die derzeit im Handel erhältlichen FK-Phasen enthalten im Regelfall beträchtliche Mengen an Esterverbindungen, z.B. der FormelThe invention is based on the object of producing liquid-crystalline phases which have a nematic phase in the required temperature range, enable sufficiently short switching times in liquid-crystal cells at room temperature, have low temperature dependency of the threshold voltage and have extremely high chemical stability. A large number of liquid-crystalline phases based on a large number of compounds are already commercially available. However, there is still a great need for liquid crystalline phases with high clearing points, low melting points, low viscosity (and thus short switching times), low temperature dependence of the threshold voltage and high chemical stability, which are suitable for multiplex operation. The LC phases currently commercially available generally contain considerable amounts of ester compounds, for example of the formula
worin R n-Alkyl oder n-Oxaalkyl und R' n-Alkyl, n-Alkoxy, n-Oxaalkyl oder CN bedeutet.wherein R is n-alkyl or n-oxaalkyl and R 'n-alkyl, n-alkoxy, n-oxaalkyl or CN.
Es wurde nun gefunden, daß Flüssigkristallphasen mit besonders günstigen Kombinationen von Materialeigenschaften, insbesondere außerordentlich hoher chemischer Stabilität und besonders guten Multiplexeigenschaften erhalten werden,It has now been found that liquid crystal phases with particularly favorable combinations of material properties, in particular extraordinarily high chemical stability and particularly good multiplex properties, are obtained,
wenn sie mindestens eine Komponente der Formel Iif they have at least one component of the formula I
R1-A-Ph-R2 R 1 -A-Ph-R 2
worin R1 Alkyl mit 1 bis 12 C-Atomen, R2 Alkyl, Alkoxy oder Alkanoyloxy mit jeweils 1 bis 12 C-Atomen,in which R 1 is alkyl having 1 to 12 C atoms, R 2 alkyl, alkoxy or alkanoyloxy each having 1 to 12 C atoms,
A Cy oder Dio,A Cy or Dio,
Dio trans-1,3-Dioxan-2,5-diyl,Dio trans-1,3-dioxane-2,5-diyl,
Cy trans-1,4-Cyclohexylen undCy trans-1,4-cyclohexylene and
Ph 1,4-Phenylen bedeutet, mindestens eine Komponente der Formel IIPh means 1,4-phenylene, at least one component of formula II
R3-Cy-Z1-Q-Z2-Phe-A°-R4 IIR 3 -Cy-Z 1 -QZ 2 -Phe-A ° -R 4 II
worin R3 und R4 jeweils Alkyl mit 1 bis 12 C-Atomen,in which R 3 and R 4 are each alkyl having 1 to 12 carbon atoms,
Cy trans 1,4-Cyclohexylen, Z 1 und Z2 jeweils unabhängig voneinanderCy trans 1,4-cyclohexylene, Z 1 and Z 2 each independently
-CO-O-, -O-CO-, -CH2CH2- oder eine Einfachbindung, Q Phe oder Cy,-CO-O-, -O-CO-, -CH 2 CH 2 - or a single bond, Q Phe or Cy,
A° trans-1,4-Cyclohexylen, trans-1,3- Dioxan-2,5-diyl oder eine Einfachbindung undA ° trans-1,4-cyclohexylene, trans-1,3-dioxane-2,5-diyl or a single bond and
Phe jeweils unsubstituiertes oder durch ein Fluor substituiertes 1,4-Phenylen bedeutet,Phe in each case means 1,4-phenylene which is unsubstituted or substituted by a fluorine,
mindestens eine Komponete ausgewählt aus den Verbindungen der Formeln lila und Illbat least one component selected from the compounds of the formulas purple and illb
R5-(Cy)m-Pyr-Phe-R6 lIlaR 5 - (Cy) m -Pyr-Phe-R 6 III
R5-(Cy)m-A1-Pyr-R6 IllbR 5 - (Cy) m -A 1 -Pyr-R 6 Illb
worin R5 jeweils Alkyl mit 1 bis 12 C-Atomen, R6 Alkyl, Alkoxy oder Alkanoyloxy mit jeweils 1 bis 12 C-Atomen, m 0 oder 1,in which R 5 in each case alkyl with 1 to 12 C atoms, R 6 alkyl, alkoxy or alkanoyloxy with in each case 1 to 12 C atoms, m 0 or 1,
Pyr Pyrimidin-2,5-diyl odor Pyridin- 2,5-diyl und A1 Phe oder Cy bedeutet und Cy und Phe die angegebenen Bedeutungen haben, und/oder mindestens eine Komponente ausgewählt aus den Verbindungen der Formeln IVa und IVbPyr pyrimidine-2,5-diyl or pyridine-2,5-diyl and A 1 means Phe or Cy and Cy and Phe have the meanings given, and / or at least one component selected from the compounds of the formulas IVa and IVb
R7-Dio-Phe-CN IVaR 7 -Dio-Phe-CN IVa
R7-A°-Phe-NCS IVb worin R7 jeweils Alkyl mit 1 bis 12 C-Atomen, A° -Cy-, -Dio-, -Cy-Phe-, -Cy-Cy-, -Cy-Ph-CO-O- oder -Cy-CH2CH2- bedeutet, und Dio und Phe die angegebene Bedeutung haben, enthalten.R 7 -A ° -Phe-NCS IVb in which R 7 each alkyl with 1 to 12 C atoms, A ° -Cy-, -Dio-, -Cy-Phe-, -Cy-Cy-, -Cy-Ph- CO-O- or -Cy-CH 2 CH 2 - means, and Dio and Phe have the meaning given.
Vorzugsweise enthalten die erfindungsgemäßen Phasen zusätzlich mindestens eine Komponente ausgewählt aus den Verbindungen der Formeln Va und Vb,The phases according to the invention preferably additionally comprise at least one component selected from the compounds of the formulas Va and Vb,
R8-Cy-(Phe)n-CN VaR 8 -Cy- (Phe) n -CN Va
R8-Cy-Cy-(Phe)n-CN VbR 8 -Cy-Cy- (Phe) n -CN Vb
worin R8 jeweils Alkyl mit 1 bis 12 C-Atomen, n 1 oder 2 bedeutet und Cy und Phe jeweils die angegebene Bedeutungen haben.wherein R 8 each represents alkyl having 1 to 12 carbon atoms, n represents 1 or 2 and Cy and Phe each have the meanings given.
und/oder mindestens eine Komponente der Formel VI,and / or at least one component of the formula VI,
R 9-Cy-A1-Z-A2-R10 VIR 9 -Cy-A 1 -ZA 2 -R 10 VI
worin R 9 Alkyl mit 1 bis 12 C-Atomen, R10 Alkyl oder Alkoxy mit jeweils 1 biswherein R 9 is alkyl having 1 to 12 carbon atoms, R 10 alkyl or alkoxy each having 1 to
12 C-Atomen oder CN, A 1 und A2 jeweils Cy oder Phe und12 carbon atoms or CN, A 1 and A 2 each Cy or Phe and
Z -CO-O-, -O-CO- oder -CH2CH2- bedeutet. Gegenstand der Erfindung sind somit die oben beschriebenen Flüssigkristallphasen, die gegebenfalls auch zwei oder mehr pleochroitische Farbstoffe enthalten können sowie die Verwendung dieser Phasen in Flüssigkristallanzeigeelementen.Z means -CO-O-, -O-CO- or -CH 2 CH 2 -. The invention thus relates to the liquid crystal phases described above, which may also contain two or more pleochroic dyes, and the use of these phases in liquid crystal display elements.
Ferner sind Gegenstand der Erfindung Flüssigkristallanzeigeelemente, die solche Phasen enthalten.The invention furthermore relates to liquid crystal display elements which contain such phases.
Prinzipiell können als Farbstoffe alle für Guest-Host-Mischungen geeigneten pleochroitischen Farbstoffe verwendet werden. Die wichtigsten dieser Farbstoffe gehören den Klassen der Antrachinon-, Naphtochinon-, Azo-, Indigo- und/oder Perylen-Farbstoffe an.In principle, all pleochroic dyes suitable for guest-host mixtures can be used as dyes. The most important of these dyes belong to the classes of antrachinone, naphthoquinone, azo, indigo and / or perylene dyes.
Diese sind in reicher Vielfalt in der Literatur beschrieben. Der Fachmann kann sich die für den jeweiligen Anwendungszweck am besten geeigneten Farbstoffe ohne Schwierigkeiten heraussuchen. So sind z.B. Anthrachinonfarbstoffe beschrieben in EP 34 832, EP 44 893, EP 48 583, EP 54 217, EP 56 492, EP 59 036, GB 20 65 158, GB 20 65 695, GB 20 81 736, GB 20 82 196, GB 20 94 822, GB 20 94 825, JP-OS 55-123673,These are described in rich diversity in the literature. The person skilled in the art can easily select the dyes which are most suitable for the particular application. For example, Anthraquinone dyes described in EP 34 832, EP 44 893, EP 48 583, EP 54 217, EP 56 492, EP 59 036, GB 20 65 158, GB 20 65 695, GB 20 81 736, GB 20 82 196, GB 20 94 822, GB 20 94 825, JP-OS 55-123673,
JP-OS 56-112 967, JP-OS 57 165 456, JP-OS 59-020 355, DE 30 17 877, DE 30 40 102, DE 30 48 552, DE 31 00 533, DE 31 15 147, DE 31 15 762, DE 31 50 803, DE 32 01 120 und DE 33 09 045, Naphthochinonfarbstoffe beschrieben in DE 31 26 108 und 32 02 761, Azofarbstoffe inJP-OS 56-112 967, JP-OS 57 165 456, JP-OS 59-020 355, DE 30 17 877, DE 30 40 102, DE 30 48 552, DE 31 00 533, DE 31 15 147, DE 31 15 762, DE 31 50 803, DE 32 01 120 and DE 33 09 045, naphthoquinone dyes described in DE 31 26 108 and 32 02 761, azo dyes in
EP 43 904, DE 31 23 519, DE 32 45 751, DE 33 09 048, PCT WO 82/2054, GB 20 79 770, JP-OS 56-57 850, JP-OS 56-104 984, JP-PS 55-052 375, JP-OS 59-096 171, JP-OS 59-093 776, US 4,308,161, US 4,308,162, US 4,340,937, T. Uchida, C. Shishido, H. Seki und M. Wada: Mol. Cryst. Lig. Cryst. 39, 39-52 (1977) und H. Seki, C. Shishido, S. Yasui und T. Uchida: Jpn. J. Appl. Phys. 21, 191-192 (1982) und Perylene beschrieben in EP 60 895, EP 68 427 und PCT WO 82/1191.EP 43 904, DE 31 23 519, DE 32 45 751, DE 33 09 048, PCT WO 82/2054, GB 20 79 770, JP-OS 56-57 850, JP-OS 56-104 984, JP-PS 55 -052 375, JP-OS 59-096 171, JP-OS 59-093 776, US 4,308,161, US 4,308,162, US 4,340,937, T. Uchida, C. Shishido, H. Seki and M. Wada: Mol. Cryst. Lig. Cryst. 39, 39-52 (1977) and H. Seki, C. Shishido, S. Yasui and T. Uchida: Jpn. J. Appl. Phys. 21, 191-192 (1982) and perylenes described in EP 60 895, EP 68 427 and PCT WO 82/1191.
Durch geeignete Wahl der Farbstoffkomponenten und der relativen Farbstoffkonzentrationen können die erfindungsgemäßen Guest-Host-Systeme den verschiedensten Anwendungsbereichen angepaßt werden.By suitable choice of the dye components and the relative dye concentrations, the guest-host systems according to the invention can be adapted to a wide variety of applications.
Die einzelnen Verbindungen der Formeln I-VI der erfindungsgemäßen Flüssigkristallphasen sind entweder bekannt oder ihre Herstellungsweisen sind für den einschlägigen Fachmann aus dem Stand der Technik ohne weiteres abzuleiten, da sie auf in der Literatur beschriebenen Standardverfahren basieren.The individual compounds of the formulas I-VI of the liquid-crystal phases according to the invention are either known or their preparation methods can be readily derived from the prior art for the person skilled in the art, since they are based on standard processes described in the literature.
Alkoxy bzw. Alkanoyloxy bedeutet in den vorstehenden Formeln -O-Alkyl bzw. -O-CO-Alkyl. Alkyl bedeutet in allen Formeln eine geradkettige Alkylgruppe, worin auch eine nicht endständige oder zwei nicht benachbarte und nicht endständige CH2-Gruppen durch -O- oder -CH=CH- ersetzt sein könnten.In the above formulas, alkoxy or alkanoyloxy means -O-alkyl or -O-CO-alkyl. In all formulas, alkyl means a straight-chain alkyl group, in which one non-terminal or two non-adjacent and non-terminal CH 2 groups could also be replaced by -O- or -CH = CH-.
Alkyl bedeutet vorzugsweise Methyl, Ethyl, n-Propyl, n-Butyl, n-Pentyl, n-Hexyl, n-Heptyl, n-Octyl, n-Nonyl, n-Alkyoxymethyl oder n-Alkoxyethyl mit j eweils vorzu¬sweise 2 bis 7 C-Atomen oder trans-Alkenyl mit 3 bis 7 C-Atomen.Alkyl preferably means methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-alkoxymethyl or n-alkoxyethyl, preferably in each case 2 to 7 carbon atoms or trans-alkenyl with 3 to 7 carbon atoms.
Wenn die Alkylgruppen der Komponenten der Formel I bis VI 3 oder mehr Kohlenstoffatome enthalten, können diese in gerader oder verzweigter Kette angeordnet sein. In den erfindungsgemäßen Phasen werden jedoch keine Komponenten verwendet, die mehr als eine verzweigte Alkylgruppe enthalten. Derartige verzweigte Alkylgruppen enthalten im Rahmen der vorliegenden Erfindung nicht mehr als eine Kettenverzweigung; vorzugsweise handelt es sich dabei um eine Methyl- oder Ethylengruppe in 1- oder 2-Stellung des Kohlenstoffgerüstes, so daß als verzweigte Alkylgruppen insbesondere in Frage kommen: 2-Methylpropyl, 2-Methylbutyl, 1-Methylpentyl, 2-Methylpentyl, 1-Methylhexyl. In der Regel enthalten die erfindungsgemäßen flüssigkristallinen Dielektrika nur eine Komponente mit einem verzweigtkettigen Alkylrest, um gewünschtenfalls optische Aktivität zu induzieren. Zu diesem Zweck werden normalerweise nicht mehr als 10 Gewichtsprozent, vorzugsweise 0,5 bis 3 Gewichtsprozent einer Komponente mit einem verzweigten Alkylrest zugefügt. Im übrigen werden als Komponenten der erfindungsgemäßen Phase solche Verbindungen der Formel I bis IV bevorzugt verwendet, in denen die Alkylreste geradkettig sind, also Methyl, Ethyl, n-Propyl, n-Butyl, n-Pentyl, n-Hexyl, n-Heptyl, n-Octyl, n-Nonyl, n-Decyl, n-Undecyl und n-Dodecyl bedeuten.If the alkyl groups of the components of the formulas I to VI contain 3 or more carbon atoms, these can be arranged in a straight or branched chain. However, no components are used in the phases according to the invention which contain more than one branched alkyl group. Such branched alkyl groups do not contain in the context of the present invention more than one chain branch; it is preferably a methyl or ethylene group in the 1- or 2-position of the carbon skeleton, so that the following are particularly suitable as branched alkyl groups: 2-methylpropyl, 2-methylbutyl, 1-methylpentyl, 2-methylpentyl, 1-methylhexyl . As a rule, the liquid-crystalline dielectrics according to the invention contain only one component with a branched-chain alkyl radical in order to induce optical activity if desired. For this purpose, normally no more than 10% by weight, preferably 0.5 to 3% by weight, of a component with a branched alkyl radical is added. Otherwise, compounds of the formula I to IV in which the alkyl radicals are straight-chain, ie methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, are preferably used as components of the phase according to the invention. n-octyl, n-nonyl, n-decyl, n-undecyl and n-dodecyl.
A ist vorzugsweise Cy. Z 1 und Z2 in Formel II bedeuten vorzugsweise jeweils eine Einfachbindung. Ferner bevorzugt sind Verbindungen der Formel II, worin eine der Gruppen Z 1 und Z2 -CH2CH2- bedeutet und die andereA is preferably Cy. Z 1 and Z 2 in formula II preferably each represent a single bond. Preference is furthermore given to compounds of the formula II in which one of the groups Z 1 and Z 2 denotes -CH 2 CH 2 - and the other
Gruppe -CH2-CH2-, -CO-O- oder -O-CO- ist. Q ist vorzugsweise Phe.Group -CH 2 -CH 2 -, -CO-O- or -O-CO-. Q is preferably Phe.
Die erfindungsgemäßen FK-Phasen enthalten vorzugsweiseThe LC phases according to the invention preferably contain
5 bis 38, insbesondere 8 bis 23 % an einer oder mehreren Komponenten der Formel I. Besonders bevorzugt sind erfindungsgemäße FK-Phasen enthaltend 10 bis 22 % an einer oder mehreren Komponenten er Formel I. R ist vorzugsweise n-Alkyl oder n-(trans)-Alkenyl mit 2 bis 7, insbesondere mit 3 bis 5, C-Atomen oder eine Oxaalkylgruppe mit 2 bis 6 C-Atomen. R 2 ist vorzugsweise n-Alkyl oder n-Alkoxy mit jeweils 1 bis 5 C-Atomen. Vorzugsweise enthalten die erfindungsgemäßen FK-Phasen mindestens eine Verbindung der Formel I, worin R 2 n-Alkoxy bedeutet.5 to 38, in particular 8 to 23% of one or more components of the formula I. Particularly preferred are LC phases according to the invention containing 10 to 22% of one or more components of the formula I. R is preferably n-alkyl or n- (trans ) Alkenyl with 2 to 7, in particular with 3 to 5, carbon atoms or an oxaalkyl group with 2 to 6 carbon atoms. R 2 is preferably n-alkyl or n-alkoxy, each having 1 to 5 carbon atoms. Preferably The LC phases according to the invention contain at least one compound of the formula I in which R 2 is n-alkoxy.
Die erfindungsgemäßen FK-Phasen enthalten vorzugsweise 5 bis 45, insbesondere 5-35 % an einer oder mehreren Komponenten der Formel II. Besonders bevorzugt sindThe LC phases according to the invention preferably contain 5 to 45, in particular 5-35% of one or more components of the formula II. Particular preference is given to
FK-Phasen enthaltend 12 bis 27 % an einer oder mehreren Komponenten der Formel II. R 3 und R4 sind jeweils vorzugsweise unabhängig voneinander n-Alkyl oder n-Oxaalkyl mit jeweils 2 bis 7, insbesondere 3 bis 5, C-Atomen. Vorzugsweise enthalten die FK-Phasen mindestens eine Verbindung der Formel I, worin A° trans-1,4-Cyclohexylen bedeutet und/oder eine Gruppe Phe 2-Fluor-1,4-phenylen und die andere Gruppe Phe 1,4-Phenylen bedeutet.LC phases containing 12 to 27% of one or more components of the formula II. R 3 and R 4 are each preferably independently of one another n-alkyl or n-oxaalkyl each having 2 to 7, in particular 3 to 5, carbon atoms. The LC phases preferably contain at least one compound of the formula I in which A ° is trans-1,4-cyclohexylene and / or one group Phe is 2-fluoro-1,4-phenylene and the other group is Phe 1,4-phenylene .
Formel II umfaßt bevorzugt Verbindungen der Teilformein IIa bis m:Formula II preferably comprises compounds of the partial form in IIa to m:
R3-Cy-Ph-Ph-R4 IIaR 3 -Cy-Ph-Ph-R 4 IIa
R3-Cy-Cy-Phe-R4 Ilb R3-Cy-Ph-Ph-Cy-R4 IIcR 3 -Cy-Cy-Phe-R 4 Ilb R 3 -Cy-Ph-Ph-Cy-R 4 IIc
R3-Cy-Phe-Ph-R4 IldR 3 -Cy-Phe-Ph-R 4 Ild
R3-Cy-Phe-Ph-Cy-R4 IIeR 3 -Cy-Phe-Ph-Cy-R 4 IIe
R3-Cy-CH2CH2-Phe-Phe-R4 IlfR 3 -Cy-CH 2 CH 2 -Phe-Phe-R 4 Ilf
R3-Cy-CH2CH2-Phe-Phe-CH2CH2-Cy-R4 IIg R3-Cy-CH2CH2-Phe-Phe-Cy-R4 IlhR 3 -Cy-CH 2 CH 2 -Phe-Phe-CH 2 CH 2 -Cy-R 4 IIg R 3 -Cy-CH 2 CH 2 -Phe-Phe-Cy-R 4 Ilh
R3-Cy-COO-Ph-Ph-R4 IliR 3 -Cy-COO-Ph-Ph-R 4 Ili
R3-Cy-CH2CH2-Phe-CH2CH2-Phe-Cy-R4 IIjR 3 -Cy-CH 2 CH 2 -Phe-CH 2 CH 2 -Phe-Cy-R 4 IIj
R3-Cy-CH2CH2-Cy-Phe-R4 IlkR 3 -Cy-CH 2 CH 2 -Cy-Phe-R 4 Ilk
R3-Cy-CH2CH2-Cy-Phe-Cy-R4 III R3-Cy-Phe-COO-Phe-Cy-R4 IIm Vorzugsweise enthalten die erfindungsgemäße FK-Phasen sowohl mindestens eine Verbindung der Formel II, worin A° eine Einfachbindung bedeutet, als auch mindestens eine Verbindung der Formel II, worin A° trans-1,4-Cyclohexylen bedeutet.R 3 -Cy-CH 2 CH 2 -Cy-Phe-Cy-R 4 III R 3 -Cy-Phe-COO-Phe-Cy-R 4 IIm The LC phases according to the invention preferably contain both at least one compound of the formula II in which A ° denotes a single bond and at least one compound of the formula II in which A ° denotes trans-1,4-cyclohexylene.
Die erfindungsgemäßen FK-Phasen enthalten vorzugsweiseThe LC phases according to the invention preferably contain
10 bis 45, insbesondere 20-35 %, an einer oder mehreren10 to 45, in particular 20-35%, on one or more
Komponenten der Formel III. Besonders bevorzugt sindComponents of formula III. Are particularly preferred
FK-Phasen enthaltend 21 bis 33 % an einer oder mehreren Komponenten der Formel III. m ist vorzugsweise 0. R5 ist vorzugsweise n-Alkyl mit 3 bis 12, insbesondere 6 bis 9 C-Atomen. R6 ist vorzugsweise n-Alkoxy oder n- Alkyl mit 1 bis 12 C-Atomen. Vorzugsweise enthalten FK-Phasen mindestens drei, insbesondere mindestens fünf, Verbindungen der Formel III.LC phases containing 21 to 33% of one or more components of the formula III. m is preferably 0. R 5 is preferably n-alkyl having 3 to 12, in particular 6 to 9, carbon atoms. R 6 is preferably n-alkoxy or n-alkyl having 1 to 12 carbon atoms. FK phases preferably contain at least three, in particular at least five, compounds of the formula III.
Formel III a umfaßt bevorzugt Verbindungen der Teilformeln Illaa und Illab,Formula III a preferably comprises compounds of the sub-formulas Illaa and Illab,
R5-Pyr-Phe-R6 IllaaR 5 -Pyr-Phe-R 6 Illaa
R5-Cy-Pyr-Phe-R6 IIIabR 5 -Cy-Pyr-Phe-R 6 IIIab
wovon die Verbindungen der Formel Illaa besonders bevorzugt sind. Pyr ist vorzugsweise Pyrimidin-2,5-diyl. R5 ist vorzugsweise geradkettiges Alkyl mit 3 bis 9 C-Atomen. R5 ist vorzugsweise geradkettiges Alkyl oder Alkoxy mit 2 bis 9 C-Atomen. Formel Illb umfaßt bevorzugte Verbindunge der Teilformein Illba, Illbb und Illbc,of which the compounds of the formula Illaa are particularly preferred. Pyr is preferably pyrimidine-2,5-diyl. R 5 is preferably straight-chain alkyl having 3 to 9 carbon atoms. R 5 is preferably straight-chain alkyl or alkoxy having 2 to 9 carbon atoms. Formula Illb includes preferred compounds of the subforms in Illba, Illbb and Illbc,
R5-Cy-Pyr-R6 IllbaR 5 -Cy-Pyr-R 6 Illba
R5-Cy-Phe-Pyr-R6 IllbbR 5 -Cy-Phe-Pyr-R 6 Illbb
R5-Cy-Cy-Pyr-R6 Illbc wovon die Verbindungen der Formeln Illbb und Illbc besonders bevorzugt sind. R5 und R6 bedeuten jeweils bevorzugt Alkyl mit 2 bis 9 C-Atomen.R 5 -Cy-Cy-Pyr-R 6 Illbc of which the compounds of the formulas Illbb and Illbc are particularly preferred. R 5 and R 6 each preferably represent alkyl having 2 to 9 carbon atoms.
Die erfindungsgemäßen FK-Phasen enthalten vorzugsweise 5 bis 45, insbesondere 14 bis 38 %, an einer oder mehreren Komponenten der Formel IV. Besonders bevorzugt sindThe LC phases according to the invention preferably contain 5 to 45, in particular 14 to 38%, of one or more components of the formula IV. Particularly preferred
FK-Phasen enthaltend 21 bis 33 % an einer oder mehreren Komponenten der Formel IV. R7 ist vorzugsweise n-Alkyl mit 2 bis 7, insbesondere 2 bis 5, C-Atomen.LC phases containing 21 to 33% of one or more components of the formula IV. R 7 is preferably n-alkyl having 2 to 7, in particular 2 to 5, carbon atoms.
Formel IVb umfaßt Verbindungen der Teilformeln IVba bis IVbfFormula IVb includes compounds of the sub-formulas IVba to IVbf
R7-Cy-Phe-NCS IVbaR 7 -Cy-Phe-NCS IVba
R7-Dio-Phe-NCS IVbb R7-Cy-Phe-Phe-NCS IVbc R7-Cy-Cy-Phe-NCS IVbdR 7 -Dio-Phe-NCS IVbb R 7 -Cy-Phe-Phe-NCS IVbc R 7 -Cy-Cy-Phe-NCS IVbd
R7-Cy-CH2CH2-Phe-NCS IVbeR 7 -Cy-CH 2 CH 2 -Phe-NCS IVbe
R7-Cy-Ph-COO-Phe-NCS IVbf wovon Verbindungen der Formel IVba, IVbc, IVbd und IVbe besonders bevorzugt sind. R7 ist vorzugsweise geradkettiges Alkyl, Alkoxy oder (trans)-Alkenyl mit vorzugsweise 2 bis 7 C-Atomen. Phe ist vorzugsweise 1,4-Phenylen.R 7 -Cy-Ph-COO-Phe-NCS IVbf, of which compounds of the formulas IVba, IVbc, IVbd and IVbe are particularly preferred. R 7 is preferably straight-chain alkyl, alkoxy or (trans) alkenyl with preferably 2 to 7 carbon atoms. Phe is preferably 1,4-phenylene.
Bevorzugt sind erfindungsgemäße Phasen, die gleichzeitig Verbindungen der Formeln I, II, III (a und/oder b) und IV (a und/oder b) enthalten. Vorzugsweise enthalten diese Phasen Verbindungen der Formel IVa. Weiterhin bevorzugt sind Phasen, die gleichzeitig Verbindungen der Formeln I, II und IVb enthalten, wobei diese Phasen vorzugsweise drei- und vierkernige Verbindungen der Formel II enthalten (d.h. A° ist in einer oder mehreren Verbindungen der Formel II eine Einfachbindung und in einer oder mehreren Verbindungen der Formel II Cy oder Dio, vorzugsweise Cy. Vorzugsweise liegen die Verhältnisse der Gewichtsanteile der Komponenten der Formeln I bis IV in den erfindungsgemäßen FK-Phasen in den im folgenden angegebenen Bereichen.Phases according to the invention which simultaneously contain compounds of the formulas I, II, III (a and / or b) and IV (a and / or b) are preferred. These phases preferably contain compounds of the formula IVa. Preference is furthermore given to phases which simultaneously contain compounds of the formulas I, II and IVb, these phases preferably containing trinuclear and tetranuclear compounds of the formula II (ie A ° is a single bond in one or more compounds of the formula II and one or more Compounds of the formula II Cy or Dio, preferably Cy. The proportions by weight of the components of the formulas I to IV in the LC phases according to the invention are preferably in the ranges given below.
I II = 0,63 - 1,53I II = 0.63-1.53
I II = 0,67 - 0,82I II = 0.67-0.82
I IV = 0,71 - 1,64I IV = 0.71-1.64
II II = 0,45 - 1,25II II = 0.45 - 1.25
II IV = 0,48 - 2,50II IV = 0.48 - 2.50
III IV = 0,90 - 2,35III IV = 0.90-2.35
Ferner bevorzugt sind erfindungsgemäße FK-Phasen enthaltend mindestens eine Komponente der Formel Va und/oder Vb, worin R8 vorzugsweise n-Alkyl mit 2 bis 7 C-Atomen bedeutet und Phe 1,4-Phenylen oder 3-Fluor-1,4-Phenylen ist.Also preferred are LC phases according to the invention containing at least one component of the formula Va and / or Vb, in which R 8 preferably denotes n-alkyl having 2 to 7 C atoms and Phe 1,4-phenylene or 3-fluoro-1,4- Is phenylene.
Der Anteil dieser Verbindung(en) liegt vorzugsweise im Bereich von 4 bis 15 %. Verbindungen der Formel Va sind bevorzugt.The proportion of this compound (s) is preferably in the range from 4 to 15%. Compounds of formula Va are preferred.
Ferner bevorzugt sind erfindungsgemäße FK-Phasen enthaltend mindestens eine Komponente der Formel VI, worin R 9 vorzugsweise n-Alkyl oder n-Oxaalkyl mit 2 bisAlso preferred are LC phases according to the invention containing at least one component of the formula VI, in which R 9 is preferably n-alkyl or n-oxaalkyl having 2 to
5 C-Atomen, R10 vorzugsweise n-Alkyl, n-Alkoxy oder n-Oxaalkyl mit jeweils 2 bis 7 C-Atomen oder CN bedeutet. A1 ist vorzugsweise trans-1,4-Cyclohexylen oder 1,4-Phenylen. A 2 i.st vorzugsweise trans-1,4-Cyclohexylen oder 3-Fluor-1,4-Phenylen. Z ist vorzugsweise -CO-O- oder -CH2CH2-. Der Anteil dieser Verbindungen beträgt vorzugsweise 3 bis 15 %. Die Herstellung der erfindungsgemäßen Phasen erfolgt in an sich üblicher Weise. In der Regel wird die gewünschte Menge der in geringerer Menge verwendeten Komponenten in der den Hauptbestandteil ausmachenden Komponenten gelöst, zweckmäßig bei erhöhter Temperatur. Wenn dabei eine Temperatur oberhalb des Klärpunkts des Hauptbestandteils gewählt wird, kann die Vollständigkeit des Lösevorgangs besonders leicht beobachtet werden.5 carbon atoms, R 10 is preferably n-alkyl, n-alkoxy or n-oxaalkyl each having 2 to 7 carbon atoms or CN. A 1 is preferably trans-1,4-cyclohexylene or 1,4-phenylene. A 2 is preferably trans-1,4-cyclohexylene or 3-fluoro-1,4-phenylene. Z is preferably -CO-O- or -CH 2 CH 2 -. The proportion of these compounds is preferably 3 to 15%. The phases according to the invention are produced in a conventional manner. As a rule, the desired amount of the components used in smaller amounts is dissolved in the components which make up the main constituent, advantageously at elevated temperature. If a temperature above the clearing point of the main constituent is chosen, the completeness of the dissolving process can be observed particularly easily.
Es ist jedoch auch möglich, Lösungen der Komponenten in einem geeigneten organischen Lösungsmittel, zumHowever, it is also possible to use solutions of the components in a suitable organic solvent
Beispiel Aceton, Chloroform oder Methanol, zu mischen und das Lösungsmittel nach gründlicher Durchmischung wieder zu entfernen, beispielsweise durch Destillation unter vermindertem Druck. Selbstverständlich muß bei dieser Verfahrensweise darauf geachtet werden, daß durch das Lösungsmittel keine Verunreinigungen oder unerwünschten Dotierungsstoffe eingeschleppt werden.Example, mix acetone, chloroform or methanol and remove the solvent after thorough mixing, for example by distillation under reduced pressure. Of course, with this procedure, care must be taken to ensure that no impurities or undesirable dopants are introduced by the solvent.
Durch geeignete Zusätze können die flüssigkristallinen Phasen nach der Erfindung so modifiziert werden, daß sie in allen bisher bekannt gewordenen Arten von Flüssigkristallanzeigeelementen verwendet werden können.By means of suitable additives, the liquid-crystalline phases according to the invention can be modified so that they can be used in all types of liquid-crystal display elements which have hitherto become known.
Derartige Zusätze sind dem Fachmann bekannt und in der Literatur ausführlich beschrieben. Beispielsweise können Leitsalze, vorzugsweise Ethyl-dimethyl-dodecylammonium-4-hexylocybenzoat, Tetrabutylammonium-tetraphenylboranat oder Komplexsalze von Kronethern (vgl. z.B. I. Haller et al., Mol. Cryst. Lig. Cryst. Band 24, Seiten 249-258, (1973)) zur Verbesserung der Leitfähigkeit oder Substanzen zur Veränderung der dielektrischen Anisotro,pie, der Viskosität und/oder der Orientierung der nematischen Phasen zugesetzt werden. Derartige Substanzen sind z.B. in den DE-OS 22 09 127, 22 40 864, 23 21 632, 23 38 281, 24 50 088, 26 37 430, 28 53 728 und 29 02 177 beschrieben.Such additives are known to the person skilled in the art and are described in detail in the literature. For example, conductive salts, preferably ethyl-dimethyl-dodecylammonium-4-hexylocybenzoate, tetrabutylammonium-tetraphenylboranate or complex salts of crown ethers (see, for example, I. Haller et al., Mol. Cryst. Lig. Cryst. Volume 24, pages 249-258, ( 1973)) to improve the conductivity or substances to change the dielectric anisotropy, pie, the viscosity and / or the orientation of the nematic phases are added. Such substances are described, for example, in DE-OS 22 09 127, 22 40 864, 23 21 632, 23 38 281, 24 50 088, 26 37 430, 28 53 728 and 29 02 177.
Die folgenden Beispiele sollen die Erfindungen erläutern, ohne sie zu begrenzen. In den Beispielen sind Schmelzpunkt und Klärpunkt einer flüssigkristallinen Substanz in Grad Celsius angegeben. Die Prozentzahlen beziehen sich auf die Gewichtsprozente.The following examples are intended to illustrate the inventions without limiting them. In the examples, the melting point and clearing point of a liquid-crystalline substance are given in degrees Celsius. The percentages relate to percentages by weight.
Beispiel 1example 1
Eine flüssigkristalline Phase ausA liquid crystalline phase
6 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,6% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
14 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan,14% 2-p-cyanophenyl-5-butyl-1,3-dioxane,
11 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan,11% 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
6 % p-trans-4-Ethylcyclohexyl-benzoesäure- (p-cyanphenylester)6% p-trans-4-ethylcyclohexyl-benzoic acid (p-cyanophenyl ester)
7 % p-trans-4-Pentylcyclohexyl-benzoesäure- (p-cyanphenylester) 2 % p-(p-Pentylbenzoyloxy)-benzoesäure-(pcyanphenylester), 18 % Buttersäure-(p-trans-4-propylcyclohexyl- phenylester), 5 % trans-1-p-Methoxyphenyl-4-propylcyclohexan, 5 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2- fluorbiphenyl, 7 % 2-p-Pentyloxyphenyl-5-hexylpyrimidin, 7 % 2-p-Hexyloxyphenyl-5-hexylpyrimidin, 7 % 2-p-Heptyloxyphenyl-5-hexylpyrimidin und 7 % 2-p-Nonyloxyphenyl-5-hexylpyrimidin7% p-trans-4-pentylcyclohexylbenzoic acid (p-cyanophenyl ester) 2% p- (p-pentylbenzoyloxy) benzoic acid (pcyanophenyl ester), 18% butyric acid (p-trans-4-propylcyclohexylphenyl ester), 5 % trans-1-p-methoxyphenyl-4-propylcyclohexane, 5% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl, 7% 2-p-pentyloxyphenyl-5-hexylpyrimidine, 7% 2- p-hexyloxyphenyl-5-hexylpyrimidine, 7% 2-p-heptyloxyphenyl-5-hexylpyrimidine and 7% 2-p-nonyloxyphenyl-5-hexylpyrimidine
hat einen Klärpunkt von 65,5°, eine dielektrische Anisotropie von +10,6, eine optische Anisotropie von 0,129, eine Schwellenspannung V10,0,20 = 1,5 Volt und ein K3/K1 von 0,92. Beispiel 2has a clearing point of 65.5 °, a dielectric anisotropy of +10.6, an optical anisotropy of 0.129, a threshold voltage V 10.0.20 = 1.5 volts and a K 3 / K 1 of 0.92. Example 2
Eine flüssigkristalline Phase ausA liquid crystalline phase
5 % 2-p-Cyanphenyl-5-ethyl-1,3-dioxan,5% 2-p-cyanophenyl-5-ethyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,7% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
8 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan,8% 2-p-cyanophenyl-5-butyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan,7% 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
6 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-biphenyl,6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl,
4 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-biphenyl, 5 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2- fluorbiphenyl,4% 4,4'-bis (trans-4-pentylcyclohexyl) biphenyl, 5% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl,
6 % 2-p-pentyloxyphenyl-5-hexylpyrimidin,6% 2-p-pentyloxyphenyl-5-hexylpyrimidine,
6 % 2-p-Hexyloxyphenyl-5-hexylpyrimidin,6% 2-p-hexyloxyphenyl-5-hexylpyrimidine,
6 % 2-p-Heptyloxyphenyl-5-hexylpyrimidin, 5 % 2-p-Nonyloxylphenyl-5-hexylpyrimidin,6% 2-p-heptyloxyphenyl-5-hexylpyrimidine, 5% 2-p-nonyloxylphenyl-5-hexylpyrimidine,
5 % 2-p-Nonyloxylphenyl-5-heptylpyrimidin,5% 2-p-nonyloxylphenyl-5-heptylpyrimidine,
5 % 2-p-Heptyloxyphenyl-5-heptylpyrimidin,5% 2-p-heptyloxyphenyl-5-heptylpyrimidine,
4 % trans-4-Pentylcyclohexancarbonsäure-(p-trans- 4-propylcyclohexylphenylester), 10 % trans-1-p-Methoxyphenyl-4-propylcyclohexan und4% trans-4-pentylcyclohexane carboxylic acid (p-trans-4-propylcyclohexylphenyl ester), 10% trans-1-p-methoxyphenyl-4-propylcyclohexane and
11 % trans-1-p-Propylphenyl-4-pentylcyclohexan11% trans-1-p-propylphenyl-4-pentylcyclohexane
hat einen Schmelzpunkt von -14°, einen Klärpunkt von 68,2°, eine dielektrische Anisotropie von +7,4, eine optische Anisotropie von 0,125, eine Schwellenspannung V10,0,20 von 2,1 Volt und K3/K1 von 0,81.has a melting point of -14 °, a clearing point of 68.2 °, a dielectric anisotropy of +7.4, an optical anisotropy of 0.125, a threshold voltage V 10.0.20 of 2.1 volts and K 3 / K 1 of 0.81.
Beispiel 3Example 3
Eine flüssigkristalline Phase ausA liquid crystalline phase
5 % 2-p-Cyanphenyl-5-ethyl-1,3-dioxan, 7 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan, 8 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan, 7 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan,5% 2-p-cyanophenyl-5-ethyl-1,3-dioxane, 7% 2-p-cyanophenyl-5-propyl-1,3-dioxane, 8% 2-p-cyanophenyl-5-butyl-1, 3-dioxane, 7% 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
6 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-biphenyl,6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl,
4 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-biphenyl,4% 4,4'-bis (trans-4-pentylcyclohexyl) biphenyl,
5 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2- fluorbiphenyl,5% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl,
6 % 2-p-Pentyloxyphenyl-5-hexylpyrimidin,6% 2-p-pentyloxyphenyl-5-hexylpyrimidine,
6 % 2-p-Hexyloxyphenyl-5-hexyIpyrimidin,6% 2-p-hexyloxyphenyl-5-hexyipyrimidine,
6 % 2-p-Heptyloxyphenyl-5-hexyIpyrimidin,6% 2-p-heptyloxyphenyl-5-hexylipyrimidine,
5 % 2-p-Nonyloxylphenyl-5-hexylpyrimidin,5% 2-p-nonyloxylphenyl-5-hexylpyrimidine,
5 % 2-p-NonyloxyIphenyl-5-heptyIpyrimidin,5% 2-p-nonyloxyIphenyl-5-heptyIpyrimidine,
5 % 2-p-Heptyloxyphenyl-5-heptylpyrimidin,5% 2-p-heptyloxyphenyl-5-heptylpyrimidine,
3 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-fluorbiphenyl,3% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-fluorobiphenyl,
8 % trans-1-p-Methoxyphenyl-4-propylcyclohexan und 5 % trans-1-p-Propylphenyl-4-pentylcyclohexan8% trans-1-p-methoxyphenyl-4-propylcyclohexane and 5% trans-1-p-propylphenyl-4-pentylcyclohexane
hat einen Schmelzpunkt von -14°, keinen Phasenübergang smektisch/nematisch bis -40°, einen Klärpunkt von 64,4°, eine dielektrische Anisotropie von +7,1, eine optische Anisotropie von 0,1248, eine Schwellenspannung V10,0,20 von 2,0 Volt und ein K3/K1 von 0,80.has a melting point of -14 °, no smectic / nematic phase transition to -40 °, a clearing point of 64.4 °, a dielectric anisotropy of +7.1, an optical anisotropy of 0.1248, a threshold voltage V 10.0, 20 of 2.0 volts and a K 3 / K 1 of 0.80.
Beispiel 4Example 4
Eine flüssigkristalline Phase ausA liquid crystalline phase
7 % 2-p-Cyanphenyl-5-ethyl-1,3-dioxan, 11 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,7% 2-p-cyanophenyl-5-ethyl-1,3-dioxane, 11% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
11 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan, 9 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan,11% 2-p-cyanophenyl-5-butyl-1,3-dioxane, 9% 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
12 % p-trans-4-Propylcyclohexyl-benzonitril,12% p-trans-4-propylcyclohexyl-benzonitrile,
6 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-biphenyl, 6 % 4-(trans-4-Pentylcyclohexyl)-4'-{trans-4- propylcyclohexyl)-biphenyl,6% 4,4'-bis (trans-4-pentylcyclohexyl) biphenyl, 6% 4- (trans-4-pentylcyclohexyl) -4 '- {trans-4-propylcyclohexyl) biphenyl,
8 % trans-1-p-Methoxyphenyl-4-propylcyclohexan, 4 % 2-p-Methoxyphenyl-5-heptylpyrimidin,8% trans-1-p-methoxyphenyl-4-propylcyclohexane, 4% 2-p-methoxyphenyl-5-heptylpyrimidine,
6 % 2-p-Nonyloxyphenyl-5-heptylpyrimidin,6% 2-p-nonyloxyphenyl-5-heptylpyrimidine,
4 % 2-p-Methoxyphenyl-5-nonylpyrimidin,4% 2-p-methoxyphenyl-5-nonylpyrimidine,
8 % 2-p-Hexyloxyphenyl-5-nonylpyrimidin und 8 % 2-p-Nonyloxyphenyl-5-nonylpyrimidin8% 2-p-hexyloxyphenyl-5-nonylpyrimidine and 8% 2-p-nonyloxyphenyl-5-nonylpyrimidine
hat einen Kläirpunkt von 62°, eine optische Anisotropie von 0,129 und eine Schwellenspannung V10,0,20 von 1,6 Volt.has a clearing point of 62 °, an optical anisotropy of 0.129 and a threshold voltage V 10.0.20 of 1.6 volts.
Beispiel 5Example 5
Eine flüssigkristalline Phase ausA liquid crystalline phase
5 % 2-p-Cyanphenyl-5-ethyl-1,3-dioxan,5% 2-p-cyanophenyl-5-ethyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,7% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
8 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan,8% 2-p-cyanophenyl-5-butyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan, 10 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)-biphenyl,7% 2-p-cyanophenyl-5-pentyl-1,3-dioxane, 10% 4-ethyl-4 '- (trans-4-pentylcyclohexyl) biphenyl,
5 % 2-p-Pentoxyphenyl-5-hexylpyrimidin,5% 2-p-pentoxyphenyl-5-hexylpyrimidine,
5 % 2-p-Hexoxyphenyl-5-hexylpyrimidin,5% 2-p-hexoxyphenyl-5-hexylpyrimidine,
5 % 2-p-Heptoxyphenyl-5-hexyIpyrimidin,5% 2-p-heptoxyphenyl-5-hexyipyrimidine,
5 % 2-p-Nonoxyphenyl-5-hexylpyrimidin, 5 % 2-p-Heptoxyphenyl-5-heptylpyrimidin,5% 2-p-nonoxyphenyl-5-hexylpyrimidine, 5% 2-p-heptoxyphenyl-5-heptylpyrimidine,
5 % 2-p-Nonoxyphenyl-5-heptylpyrimidin,5% 2-p-nonoxyphenyl-5-heptylpyrimidine,
6 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl,6% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl,
5 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-biphenyl, 8 % trans-1-p-Methoxyphenyl-4-propylcyclohexan und5% 4,4'-bis (trans-4-pentylcyclohexyl) biphenyl, 8% trans-1-p-methoxyphenyl-4-propylcyclohexane and
14 % trans-1-p-Propylphenyl-4-pentylcyclohexan14% trans-1-p-propylphenyl-4-pentylcyclohexane
hat einen Schmelzpunkt von -12°, einen Klärpunkt von 65°, eine dielektrische Anisotrooie von +7,0, eine optische Anisotropie von 0,1249, eine Schwellenspannung V10,0,20 von 2,0 Volt und im K3/K1 von 0,77. Beispiel 6has a melting point of -12 °, a clearing point of 65 °, a dielectric anisotropy of +7.0, an optical anisotropy of 0.1249, a threshold voltage V 10.0.20 of 2.0 volts and in the K 3 / K 1 in 0.77. Example 6
Eine flüssigkristalline Phase ausA liquid crystalline phase
8 % p-trans-4-Propylcyclohexyl-benzonitril,8% p-trans-4-propylcyclohexyl-benzonitrile,
7 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan,7% 2-p-cyanophenyl-5-butyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan,7% 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
12 % trans-1-p-Methoxyphenyl-4-propylcyclohexan,12% trans-1-p-methoxyphenyl-4-propylcyclohexane,
11 % trans-1-p-Butoxyphenyl-4-propylcyclohexan,11% trans-1-p-butoxyphenyl-4-propylcyclohexane,
12 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)-biphenyl,12% 4-ethyl-4 '- (trans-4-pentylcyclohexyl) biphenyl,
7 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)-biphenyl,7% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl,
5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-biphenyl, 5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-fluorbiphenyl, 5 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl,5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl, 5% 4- (trans-4-pentylcyclohexyl) -4' - (trans-4-propylcyclohexyl) -2- fluorobiphenyl, 5% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl,
4 % 2-p-Methoxyphenyl-5-hexylpyrimidin, 4 % 2-p-Methoxyphenyl-5-heptylpyrimidin, 4 % 2-p-Heptoxyphenyl-5-heptylpyrimidin, 4 % 2-p-Nonoxyphenyl-5-heptylpyrimidin und 4 % 2-p-Methoxyphenyl-5-nonylpyrimidin4% 2-p-methoxyphenyl-5-hexylpyrimidine, 4% 2-p-methoxyphenyl-5-heptylpyrimidine, 4% 2-p-heptoxyphenyl-5-heptylpyrimidine, 4% 2-p-nonoxyphenyl-5-heptylpyrimidine and 4% 2-p-methoxyphenyl-5-nonylpyrimidine
hat einen Schmelzpunkt von -18°, einen Klärpunkt von 85°, eine dielektrische Anisotropie von +5,7, eine optische Anisotropie von 0,1358, eine Schwellenspannung V10,0,20 von 2,5 Volt und ein K3/K1 von 0,94.has a melting point of -18 °, a clearing point of 85 °, a dielectric anisotropy of +5.7, an optical anisotropy of 0.1358, a threshold voltage V 10.0.20 of 2.5 volts and a K 3 / K 1 of 0.94.
Beispiel 7Example 7
Eine flüssigkristalline Phase bestehend ausA liquid crystalline phase consisting of
7 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,7% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
8 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan, 7 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan,8% 2-p-cyanophenyl-5-butyl-1,3-dioxane, 7% 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
13 % trans-1-p-Methoxyphenyl-4-propylcyclohexan,13% trans-1-p-methoxyphenyl-4-propylcyclohexane,
10 % trans-1-p-Butoxyphenyl-4-propylcyclohexan,10% trans-1-p-butoxyphenyl-4-propylcyclohexane,
2 % 4-Nonyl-4'-(trans-4-butylcyclohexyl)-biphenyl, 11 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)- biphenyl,2% 4-nonyl-4 '- (trans-4-butylcyclohexyl) biphenyl, 11% 4-ethyl-4' - (trans-4-pentylcyclohexyl) biphenyl,
2 % 4-Nonyl-4'-(trans-4-pentylcyclohexyl)- biphenyl,2% 4-nonyl-4 '- (trans-4-pentylcyclohexyl) biphenyl,
6 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-biphenyl,6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl,
5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-fluorbiphenyl,5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-fluorobiphenyl,
4 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-biphenyl,4% 4,4'-bis (trans-4-pentylcyclohexyl) biphenyl,
5 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl,5% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl,
4 % 2-p-Methoxyphenyl-5-hexylpyrimidin,4% 2-p-methoxyphenyl-5-hexylpyrimidine,
4 % 2-p-Methoxyphenyl-5-heptylpyrimidin,4% 2-p-methoxyphenyl-5-heptylpyrimidine,
5 % 2-p-Heptoxyphenyl-5-heptylpyrimidin,5% 2-p-heptoxyphenyl-5-heptylpyrimidine,
3 % 2-p-Nonoxyphenyl-5-heptylpyrimidin und 4 % 2-p-Methoxyphenyl-5-nonylpyrimidin3% 2-p-nonoxyphenyl-5-heptylpyrimidine and 4% 2-p-methoxyphenyl-5-nonylpyrimidine
hat einen Schmelzpunkt von -19°, einen Klärpunkt von 90°, eine optische Anisotropie von 0,1348, eine Schwellenspannung V10,0,20 von 2,5 Volt und ein K3/K1 von 0,92.has a melting point of -19 °, a clearing point of 90 °, an optical anisotropy of 0.1348, a threshold voltage V 10.0.20 of 2.5 volts and a K 3 / K 1 of 0.92.
Beispiel 8Example 8
Eine flüssigkristaliine Phase bestehend ausA liquid crystalline phase consisting of
5 % 2-p-Cyanphenyl-5-ethyl-1,3-dioxan,5% 2-p-cyanophenyl-5-ethyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,7% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
8 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan, 7 % a 2-p-Cyanphenyl-5-pentyl-1,3-dioxan, 5 % p-(5-Hexylpyrimidinyl)-phenyl-p-pentylbenzylether, 10 % p-(5-Heptylpyrimidinyl)-phenyl-p-pentyl benzylether,8% 2-p-cyanophenyl-5-butyl-1,3-dioxane, 7% a 2-p-cyanophenyl-5-pentyl-1,3-dioxane, 5% p- (5-hexylpyrimidinyl) phenyl-p pentylbenzyl ether, 10% p- (5-heptylpyrimidinyl) phenyl-p-pentyl benzyl ether,
8 % p-(5-Heptylpyrimidinyl)-phenyl-p-hexylbenzylether,8% p- (5-heptylpyrimidinyl) phenyl-p-hexylbenzyl ether,
5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-fluorbiphenyl,5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-fluorobiphenyl,
5 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl,5% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl,
10 % trans-1-p-Methoxyphenyl-4-propylcyclohexan, 5 % 2-p-Methoxyphenyl-5-hexylpyrimidin, 5 % 2-p-Pentoxyphenyl-5-hexylpyrimidin, 5 % 2-p-Heptoxyphenyl-5-hexylpyrimidin, 5 % 2-p-Methoxyphenyl-5-heptylpyrimidin, 5 % 2-p-Heptoxyphenyl-5-heptylpyrimidin und 5 % 2-p-Nonoxyphenyl-5-heptylpyrimidin10% trans-1-p-methoxyphenyl-4-propylcyclohexane, 5% 2-p-methoxyphenyl-5-hexylpyrimidine, 5% 2-p-pentoxyphenyl-5-hexylpyrimidine, 5% 2-p-heptoxyphenyl-5-hexylpyrimidine, 5% 2-p-methoxyphenyl-5-heptylpyrimidine, 5% 2-p-heptoxyphenyl-5-heptylpyrimidine and 5% 2-p-nonoxyphenyl-5-heptylpyrimidine
hat einen Schmelzpunkt von -14°, einen Klärpunkt von 70°, eine dielektrische Anisotropie von +8,0, eine optische Anisotropie von 0,149, eine Schwellenspannung V10,0,20 von 2,0 Volt und ein K3/K1 von 0,77.has a melting point of -14 °, a clearing point of 70 °, a dielectric anisotropy of +8.0, an optical anisotropy of 0.149, a threshold voltage V 10.0.20 of 2.0 volts and a K 3 / K 1 of 0.77.
Beispiel 9Example 9
Eine flüssigkristalline Phase bestehend ausA liquid crystalline phase consisting of
5 % 2-p-Cyanphenyl-5-ethyl-1,3-dioxan,5% 2-p-cyanophenyl-5-ethyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,7% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
8 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan, 7 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan, 4 % 4-Nonyl-4'-(trans-4-pentylcyclohexyI)-biphenyl,8% 2-p-cyanophenyl-5-butyl-1,3-dioxane, 7% 2-p-cyanophenyl-5-pentyl-1,3-dioxane, 4% 4-nonyl-4 '- (trans-4- pentylcyclohexyl) biphenyl,
11 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)-biphenyl, 5 % 2-p-Heptoxyphenyl-5-hexylpyrimidin,11% 4-ethyl-4 '- (trans-4-pentylcyclohexyl) biphenyl, 5% 2-p-heptoxyphenyl-5-hexylpyrimidine,
5 % 2-p-Nonoxyphenyl-5-hexylpyrimidin,5% 2-p-nonoxyphenyl-5-hexylpyrimidine,
5 % 2-p-Heptoxyphenyl-5-heptylpyrimidin, 5 % 2-p-Nonoxyphenyl-5-heptylpyrimidin,5% 2-p-heptoxyphenyl-5-heptylpyrimidine, 5% 2-p-nonoxyphenyl-5-heptylpyrimidine,
5 % 2-p-Hexoxyphenyl-5-nonylpyrimidin, 5 % 2-p-Nonoxyphenyl-5-nonylpyrimidin,5% 2-p-hexoxyphenyl-5-nonylpyrimidine, 5% 2-p-nonoxyphenyl-5-nonylpyrimidine,
6 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl,6% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl,
6 % trans-1-p-Methoxyphenyl-4-propylcyclohexan und 16 % trans-1-p-Propylphenyl-4-pentylcyclohexan6% trans-1-p-methoxyphenyl-4-propylcyclohexane and 16% trans-1-p-propylphenyl-4-pentylcyclohexane
hat einen Schmelzpunkt von -14°, einen Klärpunkt von 61°, eine dielektrische Anisotropie von +6,8, eine optische Anisotropie von 0,1219, eine Schwellenspannung V10,0,20 von 2,0 Volt und ein K3/K1 von 0,75.has a melting point of -14 °, a clearing point of 61 °, a dielectric anisotropy of +6.8, an optical anisotropy of 0.1219, a threshold voltage V 10.0.20 of 2.0 volts and a K 3 / K 1 in 0.75.
Beispiel 10Example 10
Eine flüssigkristalline Phase bestehend ausA liquid crystalline phase consisting of
5 % 2-p-Cyanphenyl-5-ethyl-1,3-dioxan,5% 2-p-cyanophenyl-5-ethyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,7% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
8 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan, 7 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan,8% 2-p-cyanophenyl-5-butyl-1,3-dioxane, 7% 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
7 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)- biphenyl,7% 4-ethyl-4 '- (trans-4-pentylcyclohexyl) biphenyl,
5 % 2-p-Pentoxyphenyl-5-hexylpyrimidin,5% 2-p-pentoxyphenyl-5-hexylpyrimidine,
5 % 2-p-Hexoxyphenyl-5-hexylpyrimidin, 5 % 2-p-Heptoxyphenyl-5-hexylpyrimidin,5% 2-p-hexoxyphenyl-5-hexylpyrimidine, 5% 2-p-heptoxyphenyl-5-hexylpyrimidine,
5 % 2-p-Heptoxyphenyl-5-heptylpyrimidin, 4 % 2-p-Nonoxyphenyl-5-heptylpyrimidin,5% 2-p-heptoxyphenyl-5-heptylpyrimidine, 4% 2-p-nonoxyphenyl-5-heptylpyrimidine,
6 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans¬6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans¬
4-propylcyclohexyl)-biphenyl, 4 % 4,4'-Bis-(trans-4-pentylcyclohexyl)- biphenyl, 6 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl, 4 % 4,4'-Bis-(trans-4-propylcyclohexyl)-2-fluorbiphenyl,4-propylcyclohexyl) biphenyl, 4% 4,4'-bis (trans-4-pentylcyclohexyl) biphenyl, 6% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl, 4% 4 , 4'-bis (trans-4-propylcyclohexyl) -2-fluorobiphenyl,
8 % trans-1-p-Methoxyphenyl-4-propylcyclohexan und 14 % trans-1-p-Propylphenyl-4-pentylcyclohexan hat einen Schmelzpunkt von -17°, einen Klärpunkt von 78°, eine dielektrische Anisotropie von +7,0, eine optische Anisotropie von 0,1282, eine Schwellenspannung V10,0,20 von 2,1 Volt und ein K3/K1 von 0,84.8% trans-1-p-methoxyphenyl-4-propylcyclohexane and 14% trans-1-p-propylphenyl-4-pentylcyclohexane has a melting point of -17 °, a clearing point of 78 °, a dielectric anisotropy of +7.0, an optical anisotropy of 0.1222, a threshold voltage V 10.0.20 of 2.1 volts and a K 3 / K 1 of 0.84.
Beispiel 11Example 11
Man stellt eine flüssigkristalliήe Phase her, bestehend ausA liquid-crystalline phase is produced, consisting of
5 % p-trans-4-(2-Oxapropyl)-cyclohexylbenzonitril,5% p-trans-4- (2-oxapropyl) cyclohexylbenzonitrile,
3 % p-trans-4-(3-Oxabutyl)-cyclohexylbenzonitril, 7 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan,3% p-trans-4- (3-oxabutyl) cyclohexylbenzonitrile, 7% 2-p-cyanophenyl-5-butyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan,7% 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
12 % trans-1-p-Methoxyphenyl-4-propylcyclohexan,12% trans-1-p-methoxyphenyl-4-propylcyclohexane,
11 % trans-1-p-Butoxyphenyl-4-propylcyclohexan,11% trans-1-p-butoxyphenyl-4-propylcyclohexane,
12 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)-biphenyl, 7 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)-biphenyl,12% 4-ethyl-4 '- (trans-4-pentylcyclohexyl) biphenyl, 7% 4-ethyl-4' - (trans-4-propylcyclohexyl) biphenyl,
5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-biphenyl, 5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-fluorbiphenyl, 5 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl, 4 % 2-p-Methoxyphenyl-5-hexylpyrimidin, 4 % 2-p-Methoxyphenyl-5-heptylpyrimidin, 4 % 2-p-Heptoxyphenyl-5-heptylpyrimidin, 4 % 2-p-Nonoxyphenyl-5-heptyipyrimidin und 4 % 2-p-Ethylphenyl-5-nonylpyrimidin. Beispiel 125% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl, 5% 4- (trans-4-pentylcyclohexyl) -4' - (trans-4-propylcyclohexyl) -2- fluorobiphenyl, 5% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl, 4% 2-p-methoxyphenyl-5-hexylpyrimidine, 4% 2-p-methoxyphenyl-5-heptylpyrimidine, 4% 2 -p-heptoxyphenyl-5-heptylpyrimidine, 4% 2-p-nonoxyphenyl-5-heptyipyrimidine and 4% 2-p-ethylphenyl-5-nonylpyrimidine. Example 12
Man stellt eine flüssigkristalline Phase her, bestehend ausA liquid-crystalline phase consisting of
6 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan, 14 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan,6% 2-p-cyanophenyl-5-propyl-1,3-dioxane, 14% 2-p-cyanophenyl-5-butyl-1,3-dioxane,
11 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan,11% 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
6 % p-trans-4-Ethylencyclohexyl-benzoesäure- (p-cyanphenylester)6% p-trans-4-ethylene-cyclohexyl-benzoic acid (p-cyanophenyl ester)
7 % p-trans-4-Pentylcyclohexyl-benzoesäure- (4-cyan-3-fluorphenylester),7% p-trans-4-pentylcyclohexyl-benzoic acid (4-cyan-3-fluorophenyl ester),
2 % p-(p-Pentylbenzoyloxy)-benzoesäure- (p-cyanphenylester), 18 % Buttersäure-(p-trans-4-propylcyclohexyl- phenylester), 5 % trans-1-p-Methoxyphenyl-4-propylcyclohexan, 5 % 4,4'-Bis-(trans-4-Pentylcyclohexyl)-2-fluorbiphenyl, 7 % 2-Pentyloxyphenyl-5-hexylpyrimidin, 7 % 2-Hexyloxyphenyl-5-hexylpyrimidin, 7 % 2-Heptyloxyphenyl-5-hexylpyrimidin und2% p- (p-pentylbenzoyloxy) benzoic acid (p-cyanophenyl ester), 18% butyric acid (p-trans-4-propylcyclohexyl phenyl ester), 5% trans-1-p-methoxyphenyl-4-propylcyclohexane, 5% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl, 7% 2-pentyloxyphenyl-5-hexylpyrimidine, 7% 2-hexyloxyphenyl-5-hexylpyrimidine, 7% 2-heptyloxyphenyl-5-hexylpyrimidine and
7 % 2-Nonyloxyphenyl-5-hexylpyrimidin.7% 2-nonyloxyphenyl-5-hexylpyrimidine.
Beispiel 13Example 13
Eine flüssigkristalline Phase bestehend ausA liquid crystalline phase consisting of
5 % 2-p-Cyanphenyl-5-ethyl-1,3-dioxan, 7 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,5% 2-p-cyanophenyl-5-ethyl-1,3-dioxane, 7% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
8 % 2-p-Isothiocyanatophenyl-5-butyl-1,3-dioxan, 7 % 2-p-Isothiocyanatophenyl-5-pentyl-1,3-dioxan,8% 2-p-isothiocyanatophenyl-5-butyl-1,3-dioxane, 7% 2-p-isothiocyanatophenyl-5-pentyl-1,3-dioxane,
10 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)- biphenyl 5 % 2-p-Pentyloxyphenyl-5-hexylpyrimidin, 5 % 2-p-Hexyloxyphenyl-5-hexylpyrimidin,10% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl 5% 2-p-pentyloxyphenyl-5-hexylpyrimidine, 5% 2-p-hexyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-Heptyloxyphenyl-5-hexylpyrimidin,5% 2-p-heptyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-Nonyloxyphenyl-5-hexylpyrimidin,5% 2-p-nonyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-Heptyloxyphenyl-5-heptylpyrimidin, 5 % 2-p-Nonyloxyphenyl-5-heptylpyrimidin,5% 2-p-heptyloxyphenyl-5-heptylpyrimidine, 5% 2-p-nonyloxyphenyl-5-heptylpyrimidine,
6 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl, 5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-fluorbiphenyl, 8 % 2-p-Methoxyphenyl-5-propyl-1,3-dioxan und 14 % trans-1-p-Propylphenyl-4-pentylcyclohexan6% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl, 5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-fluorobiphenyl, 8% 2-p-methoxyphenyl-5-propyl-1,3-dioxane and 14% trans-1-p-propylphenyl-4-pentylcyclohexane
hat einen Klärpunkt von 64°, eine Viskosität von 37 mm2/s bei 20° und K3/K1 (20°) von 0,73.has a clearing point of 64 °, a viscosity of 37 mm 2 / s at 20 ° and K 3 / K 1 (20 °) of 0.73.
Beispiel 14Example 14
Eine flüssigkristalline Phase bestehend ausA liquid crystalline phase consisting of
5 % trans-1-p-Isothiocyanatophenyl-4-ethylcyclohexan,5% trans-1-p-isothiocyanatophenyl-4-ethylcyclohexane,
7 % trans-1-p-Isothiocyanatophenyl-4-propylcyclohexan, 8 % 2-p-Isothiocysnatophenyl-5-butyl-1,3-dioxan,7% trans-1-p-isothiocyanatophenyl-4-propylcyclohexane, 8% 2-p-isothiocysnatophenyl-5-butyl-1,3-dioxane,
7 % 2-p-Isothiocyanatophenyl-5-pentyl-1,3-dioxan, 10 % 4-Ethyl-4'-(tians-4-propylcyclohexyl)-biphenyl, 5 % 2-p-Pentyloxyphsnyl-5-hexylpyrimidin,7% 2-p-isothiocyanatophenyl-5-pentyl-1,3-dioxane, 10% 4-ethyl-4 '- (tians-4-propylcyclohexyl) biphenyl, 5% 2-p-pentyloxyphsnyl-5-hexylpyrimidine,
5 % 2-p-Hexyloxyphenyl-5-hexylpyrimidin, 5 % 2-p-Heptyloxyphenyl-5-hexylpyrimidin,5% 2-p-hexyloxyphenyl-5-hexylpyrimidine, 5% 2-p-heptyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-Nonyloxyphenyl-5-hexylpyrimidin,5% 2-p-nonyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-Heptyloxyphenyl-5-heptylpyrimidin,5% 2-p-heptyloxyphenyl-5-heptylpyrimidine,
5 % 2-p-Nonyloxyphenyl-5-heptylpyrimidin,5% 2-p-nonyloxyphenyl-5-heptylpyrimidine,
6 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl, 5 % 4- ( trans-4-Pentylcyclohexyl ) -4 ' - ( trans-4- propylcyclohexyl)-2-fluorbiphenyl, 8 % 2-p-Methoxyphenyl-5-propyl-1,3-dioxan und 14 % trans-1-p-Propylphenyl-4-pentylcyclohexan6% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl, 5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-fluorobiphenyl, 8% 2-p-methoxyphenyl-5-propyl-1,3-dioxane and 14% trans-1 -p-propylphenyl-4-pentylcyclohexane
hat einen Klärpunkt von 66°, und Viskosität von 32 mm2/s bei 20° und K3/K1 (20°) von 0,76.has a clearing point of 66 °, and viscosity of 32 mm 2 / s at 20 ° and K 3 / K 1 (20 °) of 0.76.
Beispiel 15Example 15
Eine flüssigkristalline Phase bestehend ausA liquid crystalline phase consisting of
9 % 2-p-Isothiocyanatophenyl-5-pentyl-1,3-dioxan, 7 % 2-p-Isothiocyanatophenyl-5-heptyl-1,3-dioxan,9% 2-p-isothiocyanatophenyl-5-pentyl-1,3-dioxane, 7% 2-p-isothiocyanatophenyl-5-heptyl-1,3-dioxane,
8 % 2-p-Cyanphenyl-5-butyl-1,3-dioxan,8% 2-p-cyanophenyl-5-butyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan,7% 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
6 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-biphenyl, 4 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-biphenyl,6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl, 4% 4,4'-bis (trans-4-pentylcyclohexyl) biphenyl,
5 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl,5% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl,
6 % 2-p-Pentyloxyphenyl-5-hexylpyrimidin,6% 2-p-pentyloxyphenyl-5-hexylpyrimidine,
6 % 2-p-Hexyloxyphenyl-5-hexylpyrimidin, 6 % 2-p-Heptyloxyphenyl-5-hexylpyrimidin,6% 2-p-hexyloxyphenyl-5-hexylpyrimidine, 6% 2-p-heptyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-Nonyloxyphenyl-5-hexylpyrimidin,5% 2-p-nonyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-Heptyloxyphenyl-5-heptylpyrimidin,5% 2-p-heptyloxyphenyl-5-heptylpyrimidine,
5 % 2-p-Nonyloxyphenyl-5-heptylpyrimidin,5% 2-p-nonyloxyphenyl-5-heptylpyrimidine,
10 % 2-p-Ethoxyphenyl-5-pentyl-1,3-dioxan und 11 % trans-1-p-Propylhexyl-4-pentylcyclohexan10% 2-p-ethoxyphenyl-5-pentyl-1,3-dioxane and 11% trans-1-p-propylhexyl-4-pentylcyclohexane
hat einen Klärpunkt von 66°, eine Viskosität von 40 mm2/s bei 20° und K3/K1 (20°) von 0,82. Beispiel 16has a clearing point of 66 °, a viscosity of 40 mm 2 / s at 20 ° and K 3 / K 1 (20 °) of 0.82. Example 16
Eine flüssigkristalline Phase bestehend ausA liquid crystalline phase consisting of
9 % trans-1-p-Isothiocyanatophenyl-4-pentylcyclohexan, 7 % trans-1-p-Isothiocyanatophenyl-4-heptylcyclohexan,9% trans-1-p-isothiocyanatophenyl-4-pentylcyclohexane, 7% trans-1-p-isothiocyanatophenyl-4-heptylcyclohexane,
8 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,8% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-pentyl-1,3-dioxan,7% 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
6 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-biphenyl,6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl,
4 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-biphenyl,4% 4,4'-bis (trans-4-pentylcyclohexyl) biphenyl,
5 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl,5% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl,
6 % 2-p-Pentyloxyphenyl-5-hexylpyrimidin, 6 % 2-p-Hexyloxyphenyl-5-hexyIpyrimidin,6% 2-p-pentyloxyphenyl-5-hexylpyrimidine, 6% 2-p-hexyloxyphenyl-5-hexylipyrimidine,
6 % 2-p-Heptyloxyphenyl-5-hexylpyrimidin,6% 2-p-heptyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-Nonyloxyphenyl-5-hexylpyrimidin,5% 2-p-nonyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-Heptyloxyphenyl-5-heptylpyrimidin,5% 2-p-heptyloxyphenyl-5-heptylpyrimidine,
5 % 2-p-Nonyloxyphenyl-5-heptylpyrimidin, 10 % 2-p-Methoxyphenyl-5-pentyl-1,3-dioxan und5% 2-p-nonyloxyphenyl-5-heptylpyrimidine, 10% 2-p-methoxyphenyl-5-pentyl-1,3-dioxane and
11 % trans-1-p-Propylphenyl-4-pentylcyclohexan11% trans-1-p-propylphenyl-4-pentylcyclohexane
hat einen Klärpunkt von 67°, eine Viskosität von 38 mm2/s bei 20° und K3/K1 (20°) von 0,83.has a clearing point of 67 °, a viscosity of 38 mm 2 / s at 20 ° and K 3 / K 1 (20 °) of 0.83.
Beispiel 17Example 17
Eine flüssigkristalline Phase bestehend ausA liquid crystalline phase consisting of
15 % p-trans-4-Propylcyclohexylbenzonitril ,15% p-trans-4-propylcyclohexylbenzonitrile,
9 % trans-1-p-Isothiocyanatophenyl-4-propylcyclohexan, 5 % 4-Ethyl-4'-cyanbiphenyl, 4 % 4-Propyl-4'-cyanbiphenyl,9% trans-1-p-isothiocyanatophenyl-4-propylcyclohexane, 5% 4-ethyl-4'-cyanbiphenyl, 4% 4-propyl-4'-cyanbiphenyl,
4 % 4-Butyl-4'-cyanbiphenyl,4% 4-butyl-4'-cyanbiphenyl,
15 % trans-1-p-Ethoxyphenyl-4-propylcyclohexan,15% trans-1-p-ethoxyphenyl-4-propylcyclohexane,
9 % trans-1-p-Butoxyphenyl-4-propylcyclohexan,9% trans-1-p-butoxyphenyl-4-propylcyclohexane,
9 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)- biphenyl, 7 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)- biphenyl,9% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl, 7% 4-ethyl-4' - (trans-4-pentylcyclohexyl) biphenyl,
4 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-biphenyl,4% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl,
5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-fluorbiphenyl, 4 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-biphenyl, 5 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluor biphenyl und5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-fluorobiphenyl, 4% 4,4'-bis (trans-4-pentylcyclohexyl) biphenyl, 5% 4, 4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl and
5 % 4,4'-Bis-(trans-4-propylcyclohexyl)-2-fluor biphenyl5% 4,4'-bis (trans-4-propylcyclohexyl) -2-fluorobiphenyl
zeigt bis -40° keine smektische Phase, einen Klärpunkt von 101°, eine Viskosität von 21 mm2/s bei 20°, ein Δε von +7,3 und eine optische Anisotropie Δn von 0,154.shows no smectic phase down to -40 °, a clearing point of 101 °, a viscosity of 21 mm 2 / s at 20 °, a Δε of +7.3 and an optical anisotropy Δn of 0.154.
Beispiel 18Example 18
Eine flüssigkristalline Phase bestehend ausA liquid crystalline phase consisting of
16 % trans-1-p-Isothiocyanatophenyl-4-propylcyclohexan, 4 % trans-1-p-Cyanphenyl-4-pentylcyclohexan,16% trans-1-p-isothiocyanatophenyl-4-propylcyclohexane, 4% trans-1-p-cyanophenyl-4-pentylcyclohexane,
18 % trans-1-p-Ethylphenyl-4-propylcyclohexan,18% trans-1-p-ethylphenyl-4-propylcyclohexane,
20 % trans-1-p-Methoxylphenyl-4-propylcyclohexan,20% trans-1-p-methoxylphenyl-4-propylcyclohexane,
11 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)-biphenyl,11% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl,
11 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)-biphenyl, 4 % 4,4'-Bis-(trans-4-propylcyclohexyl)-biphenyl, 3 % 4,4'-Bis-(trans-4-propylcyclohexyl)-2-fluorbiphenyl,11% 4-ethyl-4 '- (trans-4-pentylcyclohexyl) biphenyl, 4% 4,4'-bis (trans-4-propylcyclohexyl) biphenyl, 3% 4,4'-bis (trans-4-propylcyclohexyl) -2-fluorobiphenyl,
3 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl, 6 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-biphenyl und3% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl, 6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl and
4 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-fluorbiphenyl4% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-fluorobiphenyl
zeigt bis -40° keine smektische Phase, unter Klärpunkt von 83°, eine Viskosität von 14 mm 2/s bei 20°, eine dielektrische Anisotropie Δε von +2,7 und eine optische Anisotropie Δn von 0.132.shows no smectic phase down to -40 °, below the clearing point of 83 °, a viscosity of 14 mm 2 / s at 20 °, a dielectric anisotropy Δε of +2.7 and an optical anisotropy Δn of 0.132.
Beispiel 19Example 19
Man stellt eine flüssigkristalline Phase her bestehend ausA liquid-crystalline phase is produced consisting of
16 % trans-1-p-Isothiocyanatophenyl-4-propylcyclohexan, 4 % trans-trans-4-p-Cyanphenyl-4'-pentylcyclohexylcyclohexan, 18 % trans-1-p-Ethylphenyl-4-propylcyclohexan,16% trans-1-p-isothiocyanatophenyl-4-propylcyclohexane, 4% trans-trans-4-p-cyanphenyl-4'-pentylcyclohexylcyclohexane, 18% trans-1-p-ethylphenyl-4-propylcyclohexane,
20 /o trans-1-p-Methoxylphenyl-4-propylcyclohexan,20 / o trans-1-p-methoxylphenyl-4-propylcyclohexane,
11 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)-biphenyl,11% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl,
11 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)-biphenyl,11% 4-ethyl-4 '- (trans-4-pentylcyclohexyl) biphenyl,
4 % 4,4'-Bis-(trans-4-propylcyclohexyl)-biphenyl, 3 % 4,4'-Bis-(trans-4-propylcyclohexyl)-2-fluorbiphenyl, 3 % trans, trans-4-p-Propylhexyl-4'-pentylcyclohexylcyclohexan 6 % 4- (trans-4-Pentylcyclohexyl )-4 ' - (trans-4- propylcyclohexyl)-biphenyl und 4 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-fluorbiphenyl.4% 4,4'-bis (trans-4-propylcyclohexyl) biphenyl, 3% 4,4'-bis (trans-4-propylcyclohexyl) -2-fluorobiphenyl, 3% trans, trans-4-p- Propylhexyl-4'-pentylcyclohexylcyclohexane 6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl and 4% 4- (trans-4-pentylcyclohexyl) -4' - (trans-4-propylcyclohexyl) -2- fluorobiphenyl.
Beispiel 20Example 20
Man stellt eine flüssigkristalline Phase her bestehend ausA liquid-crystalline phase is produced consisting of
16 % trans-1-p-Isothiocyanatophenyl-4-propylcyclohexan, 4 % trans-1-p-Cyanphenyl-4-pentylcyclohexan, 18 % trans-1-p-Ethylphenyl-4-propylcyclohexan, 20 % trans-1-p-Methoxylphenyl-4-propylcyclohexan, 11 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)-biphenyl, 11 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)-biphenyl, 4 % 4,4'-Bis-(trans-4-propylcyclohexyl)-biphenyl, 3 % 4,4'-Bis-(trans-4-propylcyclohexyl)-2-fluorbiphenyl,16% trans-1-p-isothiocyanatophenyl-4-propylcyclohexane, 4% trans-1-p-cyanphenyl-4-pentylcyclohexane, 18% trans-1-p-ethylphenyl-4-propylcyclohexane, 20% trans-1-p- Methoxylphenyl-4-propylcyclohexane, 11% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl, 11% 4-ethyl-4' - (trans-4-pentylcyclohexyl) biphenyl, 4% 4.4 ' - bis (trans-4-propylcyclohexyl) biphenyl, 3% 4,4'-bis (trans-4-propylcyclohexyl) -2-fluorobiphenyl,
3 % trans-trans-4-(trans-4-pentylcyclohexylethyl)- 4'-propylcyclohexylcyclohexan 6 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-biphenyl und3% trans-trans-4- (trans-4-pentylcyclohexylethyl) - 4'-propylcyclohexylcyclohexane 6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl and
4 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-f luorbiphenyl.4% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-f luorbiphenyl.
Beispiel 21Example 21
Man stellt eine flüssigkristalline Phase her bestehend ausA liquid-crystalline phase is produced consisting of
5 % 2-p-Cyanphenyl-5-ethyl-1,3-dioxan,5% 2-p-cyanophenyl-5-ethyl-1,3-dioxane,
7 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,7% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
8 % 2-p-Isothiocyantophenyl-5-butyl-1,3-dioxan, 7 % 2-p-Isothiocyantophenyl-5-pentyl-1,3-dioxan,8% 2-p-isothiocyantophenyl-5-butyl-1,3-dioxane, 7% 2-p-isothiocyantophenyl-5-pentyl-1,3-dioxane,
10 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)- biphenyl10% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl
5 % 2-p-Pentyloxyphenyl-5-hexylpyrimidin,5% 2-p-pentyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-HexyIphenyl-5-hexylpyrimidin,5% 2-p-hexylphenyl-5-hexylpyrimidine,
5 % 2-p-Heptylphenyl-5-hexylpyrimidin,5% 2-p-heptylphenyl-5-hexylpyrimidine,
5 % 2-p-Nony1oxyphenyl-5-hexylpyrimidin,5% 2-p-nonoxyphenyl-5-hexylpyrimidine,
5 % 2-p-Heptyloxyphenyl-5-heptyIpyrimidin,5% 2-p-heptyloxyphenyl-5-heptylipyrimidine,
5 % 2-p-Nonyloxyphenyl-5-heptylpyrimidin,5% 2-p-nonyloxyphenyl-5-heptylpyrimidine,
6 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl, 5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-fluorbiphenyl, 8 % 2-p-Methoxyphenyl-5-propyl-1,3-dioxan und 14 % trans-1-p-Propylphenyl-4-pentylcyclohexan.6% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl, 5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-fluorobiphenyl, 8% 2-p-methoxyphenyl-5-propyl-1,3-dioxane and 14% trans-1-p-propylphenyl-4-pentylcyclohexane.
Beispiel 22Example 22
Man stellt eine flüssigkristalline Phase her bestehend ausA liquid-crystalline phase is produced consisting of
5 % 2-p-Cyanphenyl-5-ethyl-1,3-dioxan, 7 % 2-p-Cyanphenyl-5-propyl-1,3-dioxan,5% 2-p-cyanophenyl-5-ethyl-1,3-dioxane, 7% 2-p-cyanophenyl-5-propyl-1,3-dioxane,
8 % 2-p-Isothiocyantophenyl-5-butyl-1,3-dioxan,8% 2-p-isothiocyantophenyl-5-butyl-1,3-dioxane,
7 % 2-p-Isothiocyantophenyl-5-pentyl-1,3-dioxan,7% 2-p-isothiocyantophenyl-5-pentyl-1,3-dioxane,
10 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)- biphenyl 5 % 2-p-Pentyloxyphenyl-5-hexylpyrimidin,10% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl 5% 2-p-pentyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-Hexyloxyphenyl-5-hexyipyrimidin,5% 2-p-hexyloxyphenyl-5-hexyipyrimidine,
5 % 2-p-Heptyloxyphenyl-5-hexylpyrimidin,5% 2-p-heptyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-Nonyloxyphenyl-5-hexylpyrimidin,5% 2-p-nonyloxyphenyl-5-hexylpyrimidine,
5 % 2-p-(trans-4-Pentylcyclohexyl)-phenyl-5- hexylpyrimidin, 5 % 2-(trans,trans-4-Propylcyclohexylcyclohex- 4'-yl)-5-hexylpyrimidin,5% 2-p- (trans-4-pentylcyclohexyl) phenyl-5-hexylpyrimidine, 5% 2- (trans, trans-4-propylcyclohexylcyclohex-4'-yl) -5-hexylpyrimidine,
6 % 4,4'-Bis-(trans-4-pentylcyclohexyl)-2-fluorbiphenyl, 5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4- propylcyclohexyl)-2-fluorbiphenyl, 8 % 2-p-Methoxyphenyl-5-propyl-1,3-dioxan und4 % trans-1-p-Propylphenyl-4-pentylcyclohexan.6% 4,4'-bis (trans-4-pentylcyclohexyl) -2-fluorobiphenyl, 5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-fluorobiphenyl, 8% 2-p-methoxyphenyl-5-propyl-1,3-dioxane and 4% trans-1-p-propylphenyl-4-pentylcyclohexane.
Beispiel 23Example 23
Eine flüssigkristalline Phase bestehend ausA liquid crystalline phase consisting of
16 % p-trans-4-Propylcyclohexylbenzonitril,16% p-trans-4-propylcyclohexylbenzonitrile,
5 % p-trans-4-Pentylcyclohexylbenzonitril,5% p-trans-4-pentylcyclohexylbenzonitrile,
4 % 4-Isothiocyanato-4'-(trans-4-oentylcyclohexyl)- biphenyl, 18 % trans-1-p-Ethylphenyl-4-propylcyclohexan,4% 4-isothiocyanato-4 '- (trans-4-oentylcyclohexyl) biphenyl, 18% trans-1-p-ethylphenyl-4-propylcyclohexane,
20 % trans-1-p-Methoxyphenyl-4-propylcyclohexan,20% trans-1-p-methoxyphenyl-4-propylcyclohexane,
11 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)-biphenyl,11% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl,
11 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)-biphenyl,11% 4-ethyl-4 '- (trans-4-pentylcyclohexyl) biphenyl,
4 % 4,4'-Bis-(trans-4-propylcyclohexyl)-biphenyl, 5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4-propylcyclohexyl)-biphenyl und4% 4,4'-bis (trans-4-propylcyclohexyl) biphenyl, 5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl and
5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4-prooyIcyclohexyl)-2-fluorbiphenyl5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-proylcyclohexyl) -2-fluorobiphenyl
zeigt einen Klärounkt von 30º und eine Viskosität von 15 mm2/s bei 20°. Beispiel 24shows a clear point of 30 ° and a viscosity of 15 mm 2 / s at 20 °. Example 24
Eine flüssigkristalline Phase bestehend ausA liquid crystalline phase consisting of
16 % p-trans-4-Propylcyclohexylbenzonitril,16% p-trans-4-propylcyclohexylbenzonitrile,
5 % p-trans-4-Pentylcyclohexylbenzonitril, 4 % trans,trans-4'-(p-Isothiocyanatophenyl)-4-propylcyclohexylcyclohexan,5% p-trans-4-pentylcyclohexylbenzonitrile, 4% trans, trans-4 '- (p-isothiocyanatophenyl) -4-propylcyclohexylcyclohexane,
18 % trans-1-p-Ethylphenyl-4-propylcyclohexan,18% trans-1-p-ethylphenyl-4-propylcyclohexane,
20 % trans-1-p-Methoxyphenyl-4-propylcyclohexan,20% trans-1-p-methoxyphenyl-4-propylcyclohexane,
11 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)-biphenyl, 11 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)-biphenyl,11% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl, 11% 4-ethyl-4' - (trans-4-pentylcyclohexyl) biphenyl,
4 % 4,4'-Bis-(trans-4-propylcyclohexyl)-biphenyl,4% 4,4'-bis (trans-4-propylcyclohexyl) biphenyl,
6 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4-propylcyclohexyl)-biphenyl und6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl and
5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4-propylcyclohexyl)-2-fluorbiphenyl5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-fluorobiphenyl
zeigt einen Klärpunkt von 80" und eine Viskosität von 14 mm2/s bei 20°.shows a clearing point of 80 "and a viscosity of 14 mm 2 / s at 20 °.
Beispiel 25Example 25
Man stellt eine flüssigkristalline Phase her bestehend ausA liquid-crystalline phase is produced consisting of
16 % p-trans-4-Propylcyclohexylbenzonitril,16% p-trans-4-propylcyclohexylbenzonitrile,
5 % p-trans-4-Pentylcyclohexylbenzonitril,5% p-trans-4-pentylcyclohexylbenzonitrile,
4 % 1 -(p-Isothiocyanatophenyl)-2-(trans-4- propylcyclohexyl)-ethan, 18 % trans-1-p-Ethylphenyl-4-propylcyclohexan,4% 1 - (p-isothiocyanatophenyl) -2- (trans-4-propylcyclohexyl) -ethane, 18% trans-1-p-ethylphenyl-4-propylcyclohexane,
20 % trans-1-p-Methoxyphenyl-4-propylcyclohexan, 11 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)-biphenyl. 11 % 4-Ethyl-4 ' - ( trans-4-pentylcyclohexyl ) -biphenyl ,20% trans-1-p-methoxyphenyl-4-propylcyclohexane, 11% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl. 11% 4-ethyl-4 '- (trans-4-pentylcyclohexyl) biphenyl,
4 % 4,4'-Bis-(trans-4-propylcyclohexyl)-biphenyl,4% 4,4'-bis (trans-4-propylcyclohexyl) biphenyl,
6 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4-propylcyclohexyl)-biphenyl und 5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4-propylcyclohexyl)-2-fluorbiphenyl.6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl and 5% 4- (trans-4-pentylcyclohexyl) -4' - (trans-4-propylcyclohexyl) -2- fluorobiphenyl.
Beispiel 26Example 26
Man stellt eine flüssigkristalline Phase her bestehend ausA liquid-crystalline phase is produced consisting of
16 % p-trans-4-Propylcyclohexylbenzonitril,16% p-trans-4-propylcyclohexylbenzonitrile,
5 % p-trans-4-Pentylcyclohexylbenzonitril,5% p-trans-4-pentylcyclohexylbenzonitrile,
4 % p-(trans-4-Propylcyclohexyl)-benzoesäure- (p-isothiocyanatophenylester),4% p- (trans-4-propylcyclohexyl) benzoic acid (p-isothiocyanatophenyl ester),
18 % trans-1-p-Ethylphenyl-4-propylcyclohexan, 20 % trans-1-p-Methoxyphenyl-4-propylcyclohexan,18% trans-1-p-ethylphenyl-4-propylcyclohexane, 20% trans-1-p-methoxyphenyl-4-propylcyclohexane,
11 % 4-Ethyl-4'-(trans-4-propylcyclohexyl)-biphenyl,11% 4-ethyl-4 '- (trans-4-propylcyclohexyl) biphenyl,
11 % 4-Ethyl-4'-(trans-4-pentylcyclohexyl)-biphenyl,11% 4-ethyl-4 '- (trans-4-pentylcyclohexyl) biphenyl,
4 % 4,4'-Bis-(trans-4-propylcyclohexyl)-biphenyl,4% 4,4'-bis (trans-4-propylcyclohexyl) biphenyl,
6 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4-propylcyclohexyl)-biphenyl und6% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) biphenyl and
5 % 4-(trans-4-Pentylcyclohexyl)-4'-(trans-4-propylcyclohexyl)-2-fluorbiphenyl. 5% 4- (trans-4-pentylcyclohexyl) -4 '- (trans-4-propylcyclohexyl) -2-fluorobiphenyl.

Claims

FlüssigkristallphasePatentansprüche: Liquid crystal phase
1. Flüssigkristallphase, dadurch gekennzeichnet, daß sie mindestens eine Komponente der Formel I1. Liquid crystal phase, characterized in that it contains at least one component of the formula I.
R1-A-Ph-R2 IR 1 -A-Ph-R 2 I
worin R1 Alkyl mit 1 bis 12 C-Atomen, R2 Alkyl, Alkoxy oder Alkanoyloxy mit jeweils 1 bis 12 C-Atomen,in which R 1 is alkyl having 1 to 12 C atoms, R 2 alkyl, alkoxy or alkanoyloxy each having 1 to 12 C atoms,
A Cy oder Dio,A Cy or Dio,
Dio trans-1,3-Dioxan-2,5-diyl,Dio trans-1,3-dioxane-2,5-diyl,
Cy trans-1,4-Cyclohexylen undCy trans-1,4-cyclohexylene and
Ph 1,4-Phenylen bedeutet,Ph means 1,4-phenylene,
mindestens eine Komponente der Formel IIat least one component of formula II
R3-Cy-Z1-Q-Z2-Phe-A°-R4 IIR 3 -Cy-Z 1 -QZ 2 -Phe-A ° -R 4 II
worin R3 und R4 jeweils Alkyl mit 1 bis 12 C-Atomen,in which R 3 and R 4 are each alkyl having 1 to 12 carbon atoms,
Cy trans 1,4-Cyclohexylen, Z 1 und Z2 jeweils unabhängig voneinanderCy trans 1,4-cyclohexylene, Z 1 and Z 2 each independently
-CO-O-, -O-CO-, -CH2CH2- oder eine-CO-O-, -O-CO-, -CH 2 CH 2 - or one
Einfachbindung,Single bond,
Q Phe oder Cy,Q Phe or Cy,
A° trans-1,4-Cyclohexylen, trans-1,3- Dioxan-2,5-diyl oder eine Einfachbindung undA ° trans-1,4-cyclohexylene, trans-1,3-dioxane-2,5-diyl or a single bond and
Phe jeweils unsubstituiertes oder durch ein Fluor substituiertes 1,4-Phenylen bedeutet, mindestens eine Komponente ausgewählt aus den Verbindungen der Formeln lIla und IllbPhe in each case means unsubstituted or fluorine-substituted 1,4-phenylene, at least one component selected from the compounds of the formulas IIa and IIIb
R5-(Cy)m-Pyr-Phe-R6 lIlaR 5 - (Cy) m -Pyr-Phe-R 6 III
R5-(Cy)m-A1-Pyr-R6 IllbR 5 - (Cy) m -A 1 -Pyr-R 6 Illb
worin R5 jeweils Alkyl mit 1 bis 12 C-Atomen, R6 Alkyl, Alkoxy oder Alkanoyloxy mit jeweils 1 bis 12 C-Atomen, m 0 oder 1, Pyr Pyrimidin-2,5-diyl oder Pyridin- 2,5-diyl und A1 Phe oder Cy bedeutet und Cy und Phe die angegebenen Bedeutungen haben, und/oderwherein R 5 each alkyl with 1 to 12 carbon atoms, R 6 alkyl, alkoxy or alkanoyloxy each with 1 to 12 carbon atoms, m 0 or 1, pyr pyrimidine-2,5-diyl or pyridine-2,5-diyl and A 1 denotes Phe or Cy and Cy and Phe have the meanings indicated, and / or
mindestens eine Komponente ausgewählt aus den Verbindungen der Formeln IVa und IVbat least one component selected from the compounds of the formulas IVa and IVb
R7-Dio-Phe-CN IVaR 7 -Dio-Phe-CN IVa
R7-A°-Phe-NCS IVbR 7 -A ° -Phe-NCS IVb
worin R7 jeweils Alkyl mit 1 bis 12 C-Atomen, Aº -Cy-, -Dio-, -Cy-Phe-, -Cy-Cy-, -Cy-Ph-CO-O- oder -Cy-CH2CH2- bedeutet, und Dio und Phe die angegebenen Bedeutungen haben, enthält.wherein R 7 each alkyl with 1 to 12 carbon atoms, A ° -Cy-, -Dio-, -Cy-Phe-, -Cy-Cy-, -Cy-Ph-CO-O- or -Cy-CH 2 CH 2 - means, and Dio and Phe have the meanings given.
2. Flüssigkristallphase nach Anspruch 1, dadurch gekennzeichnet, daß sie mindestens eine Komponente ausgewählt aus den Verbindungen der Formeln Va und Vb enthält2. Liquid crystal phase according to claim 1, characterized in that it contains at least one component selected from the compounds of the formulas Va and Vb
R8-Cy-(Phe)n-CN VaR 8 -Cy- (Phe) n -CN Va
R8-Cy-Cy-(Phe)n-CN Vb worin R8 jeweils Alkyl mit 1 bis 12 C-Atomen, n 1 oder 2 bedeutet und Cy und Phe jeweils die angegebene Bedeutungen haben.R 8 -Cy-Cy- (Phe) n -CN Vb wherein R 8 each represents alkyl having 1 to 12 carbon atoms, n represents 1 or 2 and Cy and Phe each have the meanings given.
3. Flüssigkristallphase nach Anspruch 1 oder 2, dadurch gekennzeichnet, daß sie mindestens eine Komponente der Formel VI enthält,3. Liquid crystal phase according to claim 1 or 2, characterized in that it contains at least one component of the formula VI,
R 9-Cy-A1-Z-A2-R10 VIR 9 -Cy-A 1 -ZA 2 -R 10 VI
worin R9 Alkyl mit 1 bis 12 C-Atomen, R10 Alkyl oder Alkoxy mit jeweils 1 biswherein R 9 is alkyl having 1 to 12 carbon atoms, R 10 alkyl or alkoxy each having 1 to
12 C-Atomen oder CN, A 1 und A2 jeweils Cy oder Phe und12 carbon atoms or CN, A 1 and A 2 each Cy or Phe and
Z -CO-O-, -O-CO- oder -CH2CH2- bedeutet.Z means -CO-O-, -O-CO- or -CH 2 CH 2 -.
Verwendung von Flüssigkristallphasen nach einem der Ansprüche 1 bis 3 für hoch multiplexierbare elektrooptische Anzeigeelemente.Use of liquid crystal phases according to one of Claims 1 to 3 for highly multiplexable electro-optical display elements.
Elektrooptisches Anzeigeelement für Multiplexbetrieb, dadurch gekennzeichnet, daß es eine Phase nach einem der Ansprüche 1 bis 3 enthält. Electro-optical display element for multiplex operation, characterized in that it contains a phase according to one of Claims 1 to 3.
EP86901864A 1985-03-25 1986-03-19 Liquid crystal phase Expired EP0226592B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3510733U 1985-03-25
DE19853510733 DE3510733A1 (en) 1985-03-25 1985-03-25 Liquid-crystal phase

Publications (2)

Publication Number Publication Date
EP0226592A1 true EP0226592A1 (en) 1987-07-01
EP0226592B1 EP0226592B1 (en) 1989-09-06

Family

ID=6266238

Family Applications (1)

Application Number Title Priority Date Filing Date
EP86901864A Expired EP0226592B1 (en) 1985-03-25 1986-03-19 Liquid crystal phase

Country Status (5)

Country Link
EP (1) EP0226592B1 (en)
JP (1) JPS62502409A (en)
KR (1) KR870700087A (en)
DE (2) DE3510733A1 (en)
WO (1) WO1986005799A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2289715B (en) * 1994-05-24 1998-02-11 Mitsui Mining & Smelting Co Vehicle door latch device with power door-closing mechanism
EP2455685A1 (en) 2010-11-22 2012-05-23 HAWE Hydraulik SE Electro-hydraulic adjustment device of a solar trough
EP2677250A1 (en) 2012-06-22 2013-12-25 HAWE Hydraulik SE Solar generator and hydraulic regulator seat valve

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3500897A1 (en) * 1985-01-12 1986-07-17 Merck Patent Gmbh, 6100 Darmstadt LIQUID CRYSTALLINE PHASE
JPS62143990A (en) * 1985-12-18 1987-06-27 Hitachi Ltd Liquid crystal display element
DE3545345A1 (en) * 1985-12-20 1987-07-02 Merck Patent Gmbh LIQUID CRYSTALINE SENFOELE
JPH0721142B2 (en) * 1985-12-25 1995-03-08 株式会社日立製作所 Liquid crystal display element
DE3606153A1 (en) * 1986-02-26 1987-08-27 Merck Patent Gmbh LIQUID CRYSTAL DISPLAY ELEMENT
DE3606787A1 (en) * 1986-03-01 1987-09-03 Merck Patent Gmbh ELECTROOPTICAL DISPLAY ELEMENT
US4913532A (en) * 1987-10-19 1990-04-03 Casio Computer Co., Ltd. Liquid crystal composition and liquid crystal display device using the same
DE3915058A1 (en) * 1989-05-09 1990-11-15 Merck Patent Gmbh LIQUID CRYSTAL DISPLAY OMI-TYPE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2067586B (en) * 1979-12-28 1984-10-10 Chisso Corp Nematic liquid crystal compositions for display apparatus
JPS5716087A (en) * 1980-07-04 1982-01-27 Hitachi Ltd Liquid crystal display device
GB2098986A (en) * 1981-05-12 1982-12-01 Secr Defence Liquid crystal diesters containing at least two phenyl groups

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8605799A1 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2289715B (en) * 1994-05-24 1998-02-11 Mitsui Mining & Smelting Co Vehicle door latch device with power door-closing mechanism
EP2455685A1 (en) 2010-11-22 2012-05-23 HAWE Hydraulik SE Electro-hydraulic adjustment device of a solar trough
EP2677250A1 (en) 2012-06-22 2013-12-25 HAWE Hydraulik SE Solar generator and hydraulic regulator seat valve

Also Published As

Publication number Publication date
DE3665478D1 (en) 1989-10-12
WO1986005799A1 (en) 1986-10-09
EP0226592B1 (en) 1989-09-06
DE3510733A1 (en) 1986-09-25
KR870700087A (en) 1987-02-28
JPS62502409A (en) 1987-09-17

Similar Documents

Publication Publication Date Title
EP0205503B1 (en) Liquid crystalline phase
EP0281611B1 (en) Liquid crystal phases for electro-optic display elements based on the ecb effect
EP0264435B1 (en) Smectic liquid crystal phases
EP0207975B1 (en) Liquid crystalline phases
EP0308438B1 (en) Liquid crystal phase containing tolanes
EP0471813B1 (en) 4,4'-disubstituted 2',3-difluorbiphenyls and liquid crystalline medium
EP0138006A2 (en) Liquid-crystal phase
EP0474062A2 (en) Matrix liquid crystal display
EP0151446B1 (en) Liquid crystal phase
EP0258349B1 (en) Electro-optical display element
EP0158137B1 (en) Pyrimidines
EP0226592B1 (en) Liquid crystal phase
EP0158252A2 (en) Liquid crystal phase
EP0302916B1 (en) Electro-optical display element
EP0450368A2 (en) Liquid crystal display and liquid crystal mixture
DE3443929A1 (en) CARBONITRILE
DE4338348B4 (en) 2,6-Disubstituted benzotrifluorides
DE3434335A1 (en) Liquid-crystalline phase
DE3711306A1 (en) Tolan derivatives, and use of carbonitriles in liquid-crystalline phases for display elements based on the ECB effect
DE3546828C1 (en) Electro-optical display element
DE3617431A1 (en) CYCLOHEXANDERIVATE
DE3831336A1 (en) Tolans
DE3631415A1 (en) Use of carbonitriles as components of liquid-crystalline phases for electro-optical display elements based on the ECB effect
DE3935106A1 (en) Nematic medium for liq. crystal displays - comprises mixt. of liq. crystalline component with min. dielectric anisotropy and pyridin-5-yl trans-substd. cyclohexane-carboxylate
DE3413148A1 (en) Liquid crystalline phase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19870213

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB LI

17Q First examination report despatched

Effective date: 19880518

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): CH DE FR GB LI

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19890906

REF Corresponds to:

Ref document number: 3665478

Country of ref document: DE

Date of ref document: 19891012

ET Fr: translation filed
GBV Gb: ep patent (uk) treated as always having been void in accordance with gb section 77(7)/1977 [no translation filed]
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19900331

Ref country code: CH

Effective date: 19900331

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Effective date: 19901130

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19930324

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19941201